SEC Form DEF 14A filed by Booz Allen Hamilton Holding Corporation

6/12/25 4:20:35 PM ET

$BAH

Professional Services

Consumer Discretionary

Get the next $BAH alert in real time by email

bah-20250611

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14-A

(RULE 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant þ

Filed by a Party other than the Registrant ¨

Check the appropriate box:

¨ Preliminary Proxy Statement

¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

þ Definitive Proxy Statement

¨ Definitive Additional Materials

¨ Soliciting Materials Pursuant to §240.14a-12

BOOZ ALLEN HAMILTON HOLDING CORPORATION

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

þ No fee required.

¨ Fee paid previously with preliminary materials.

¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Notice of 2025

Annual Meeting

of Stockholders

and Proxy Statement

July 23, 2025

Booz Allen Hamilton Holding Corporation

8283 Greensboro Drive

McLean, Virginia 22102

June 12, 2025


Dear Fellow Stockholder: I am pleased to invite you to join Booz Allen Hamilton Holding Corporation's ("Booz Allen" or the "Company") Board of Directors, senior leadership, and fellow stockholders at our Annual Meeting of Stockholders to be held at 8:00 a.m. (EDT) on July 23, 2025. Enclosed with this proxy statement are your proxy card and our 2025 annual report to stockholders.

Items of business to be transacted at our Annual Meeting are:

1.Election of twelve director nominees;

2.Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal year 2026;

3.A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;

4.If properly presented at the Annual Meeting, a non-binding advisory vote on a stockholder proposal; and

5.Consideration of any other business that may properly be brought before the Annual Meeting.

The Board of Directors recommends that you vote FOR Proposals 1, 2, and 3 and AGAINST Proposal 4.

Our 2025 Annual Meeting of Stockholders will be a virtual meeting conducted solely online and can be attended by visiting www.virtualshareholdermeeting.com/BAH2025. To participate in the Annual Meeting, you will need the control number located on your proxy card or the instructions that accompanied your proxy materials.

Your vote is important. Whether or not you plan to virtually attend the Annual Meeting, you may access electronic voting via the Internet or the automated telephone voting feature, both of which are described on your enclosed proxy card. You may also sign, date, and return the proxy card in the envelope provided.

On behalf of Booz Allen, thank you for your continued support and investment.

Sincerely,

Horacio D. Rozanski

Chairman, Chief Executive Officer, and President

NOTICE OF BOOZ ALLEN HAMILTON HOLDING CORPORATION'S 2025 ANNUAL MEETING OF STOCKHOLDERS



Time and Date:						8:00 a.m. (EDT), July 23, 2025

Place:*						Virtual meeting at www.virtualshareholdermeeting.com/BAH2025

Agenda:						1. The election of twelve director nominees named in the proxy statement;

						2. The ratification of the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year 2026;

						3. A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis section of the proxy statement;

						4. If properly presented at the Annual Meeting, a non-binding advisory vote on a stockholder proposal; and

						5. The transaction of any other business that may properly be brought before the Annual Meeting.

						The Board of Directors recommends that you vote FOR Proposals 1, 2, and 3 and AGAINST Proposal 4.

Record Date:						Only holders of record of the Company’s Class A common stock on June 2, 2025 will be entitled to vote at the Annual Meeting.

Date of Distribution:						The proxy materials or a Notice of Internet Availability were sent to stockholders on or about June 12, 2025.

Proxy Voting:						Your vote is important. Whether or not you plan to virtually attend the Annual Meeting, you may access electronic voting via the Internet or the automated telephone voting feature, both of which are described on your enclosed proxy card, or you may sign, date, and return the proxy card in the envelope provided.

* Our 2025 Annual Meeting of Stockholders will be a virtual meeting conducted solely online and can be attended by visiting www.virtualshareholdermeeting.com/BAH2025. To participate in the Annual Meeting, you will need the control number located on your proxy card or the instructions that accompanied your proxy materials. If you plan to participate in the virtual meeting, please see “Important Information About Annual Meeting and Proxy Procedures.”

On Behalf of the Board of Directors,

Jacob D. Bernstein

Secretary

June 12, 2025

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on July 23, 2025: This Notice of Annual Meeting, accompanying Proxy Statement, and our 2025 Annual Report are available at www.proxyvote.com.

TABLE OF CONTENTS TO PROXY STATEMENT


PROXY STATEMENT SUMMARY			1

PROPOSAL 1: ELECTION OF DIRECTORS			7

Election of Directors			7

Board Skills and Expertise			7

Director Nominees			7

NON-CONTINUING DIRECTORS			14

CORPORATE GOVERNANCE AND GENERAL INFORMATION CONCERNING THE BOARD OF DIRECTORS AND ITS COMMITTEES			15

Our Board of Directors			15

Corporate Governance Guidelines			15

Codes of Conduct and Ethics			15

Board Meetings and Attendance			15

Board Leadership Structure			16

Succession Planning and Talent Reviews			16

Risk Oversight			17

Annual Board Performance Assessment			17

Board Independence			18

Selection of Nominees for Election to the Board			18

Director Orientation and Continuing Education			19

Communications with the Board			19

Board Committees			20

Director Compensation			22

Director Ownership Guidelines			24

Insider Trading Policy and Policy on Hedging, Short Sales, and Speculative Transactions			24

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION			25

SECURITY OWNERSHIP INFORMATION			26

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS			28

Policies and Procedures for Related Person Transactions			28

Related Person Transactions			28

COMPENSATION DISCUSSION AND ANALYSIS			29

Executive Summary			30

Setting Executive Compensation and Peer Group			32

Compensation Elements			34

Executive Ownership Requirements			40

Risk Assessment			40


Advisory Vote to Approve Executive Compensation			40

Government Limitations on Reimbursement of Compensation Costs			41

Compensation Recovery Provisions (Clawbacks)			41

Certain Change in Control Provisions			42

Policies on Timing of Equity Grants			43

Effect on Accounting and Tax Treatment on Compensation Decisions			43

Compensation Tables and Disclosures			44

Pay Ratio			54

Pay Versus Performance			55

COMPENSATION COMMITTEE REPORT			60

AUDIT COMMITTEE REPORT			61

PRE-APPROVAL OF SERVICES BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM			62

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FEES			63

PROPOSAL 2: RATIFICATION OF APPOINTMENT OF ACCOUNTANTS			64

PROPOSAL 3: ADVISORY VOTE ON COMPANY'S EXECUTIVE COMPENSATION			65

PROPOSAL 4: STOCKHOLDER PROPOSAL			66

OTHER BUSINESS			70

IMPORTANT INFORMATION ABOUT ANNUAL MEETING AND PROXY PROCEDURES			71

WEBSITE REFERENCES			76

Appendix A			A - 1

PROXY STATEMENT SUMMARY

This summary highlights certain information contained elsewhere in this proxy statement. The summary does not contain all of the information that you should consider, and you should review our Annual Report on Form 10-K for the year ended March 31, 2025 and the entire proxy statement carefully before voting.

Unless the context otherwise indicates or requires, as used in this proxy statement, references to: (i) the “Company,” “we,” “us,” “our,” or our “company” refer to Booz Allen Hamilton Holding Corporation, its consolidated subsidiaries and predecessors; (ii) “Booz Allen Holding” or "Booz Allen" refers to Booz Allen Hamilton Holding Corporation exclusive of its subsidiaries; (iii) “Booz Allen Hamilton” refers to Booz Allen Hamilton Inc., our primary operating company and a wholly-owned subsidiary of Booz Allen Holding; (iv) “our Board” or “the Board” means the Board of Directors of the Company; (v) “stockholder” means holders of our Class A common stock; (vi) “fiscal year,” refers to our fiscal years ended March 31; and (vii) “you,” “your,” “yours,” or other words of similar import in this proxy statement refers to stockholders entitled to vote on the matters to be presented at the 2025 Annual Meeting of Stockholders (the "Annual Meeting").

2025 Annual Meeting of Stockholders

Date and Time: July 23, 2025 at 8:00 a.m. (EDT)

Place: Virtual meeting at www.virtualshareholdermeeting.com/BAH2025

Record date: June 2, 2025

Admission: Our 2025 Annual Meeting of Stockholders will be a virtual meeting conducted solely online and can be attended by visiting www.virtualshareholdermeeting.com/BAH2025. To participate in the Annual Meeting, you will need the control number located on your proxy card or the instructions that accompanied your proxy materials. If you plan to participate in the virtual meeting, please see "Important Information about Annual Meeting and Proxy Procedures."

Voting Matters and Board Recommendations

Stockholders are being asked to vote on the following matters at the 2025 Annual Meeting of Stockholders:


Proposal	Description	Board's Voting Recommendation	Page Reference
No. 1	Election of twelve director nominees	FOR each nominee	7
No. 2	Ratification of appointment of Ernst & Young LLP ("E&Y") as the Company's independent registered accounting firm for fiscal year 2026	FOR	64
No. 3	A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the Compensation Discussion and Analysis ("CD&A") of the proxy statement	FOR	65
No. 4	If properly presented at the Annual Meeting, a non-binding advisory vote on a stockholder proposal	AGAINST	66

How to Vote

Stockholders as of the record date may vote electronically at the virtual meeting or vote in advance by submitting a proxy by Internet, telephone, or mail as follows:



Vote by Internet	Vote by Telephone	Vote by Mail
Visit proxyvote.com	Call the phone number located on the top of your proxy card	Complete, sign, date and return your proxy card in envelope provided

Company Performance and Highlights

•During fiscal year 2025, we returned $1.2 billion to stockholders in the form of:

◦$268.3 million in quarterly dividends — three regular dividends of $0.51 per share and one regular dividend of $0.55 per share;

◦$763.6 million through the repurchase of 5.6 million shares of Class A common stock; and

◦$37.2 million in strategic investments.

•The Board increased the quarterly dividend 8% for performance in the third quarter of fiscal year 2025, payable in the fourth quarter of fiscal year 2025.

Our Board of Directors

Each of our directors is elected by our stockholders on an annual basis to serve until the next annual meeting and until their respective successors are elected. Each of our current directors, with the exception of Ms. Barnes, has been nominated for election to the Board, and you can find additional information regarding our Board nominees under "Proposal 1: Election of Directors" beginning on page 7. Ms. Barnes has notified the Board of her intention to not stand for re-election at the Annual Meeting. Ms. Barnes’ decision to not stand for re-election was not the result of any disagreement with the Company relating to any of our operations, policies, or practices.

Current Board Composition


Director Independence						Tenure

Age Mix

Corporate Governance Highlights

•Twelve of our thirteen current directors are independent, and the Audit, Compensation, Culture and People, and Nominating and Corporate Governance Committees are 100% independent.

•We provide for a majority voting standard in our bylaws for the election of directors in uncontested elections, with the requirement that any incumbent director nominee who does not receive a majority of the votes validly cast in an uncontested election tender his or her resignation, subject to acceptance by the Board of Directors.

•Annual election of all of our directors.

•Our directors attended 95% of the total aggregate number of Board of Directors and committee meetings in fiscal year 2025.

•The Board of Directors holds regular executive sessions of non-management directors.

•The Board of Directors conducts an annual discussion on management succession planning, with support provided by the Compensation, Culture and People Committee.

•We prohibit short sales and derivative transactions in our equity, and hedging and pledging of our equity.

•Our equity awards include a provision for the recoupment of equity-based compensation in the event of misconduct leading to a financial restatement.

•Our Investor Relations team and management regularly engage with current and potential stockholders.

•We do not have a poison pill in place.

•We adhere to robust executive officer and director stock ownership guidelines.

•We conduct annual Board and committee evaluations and self-assessments.

•We adhere to a sound policy on public company board service to ensure a director's ability to devote necessary time to serve on our Board.

•Stockholders who hold at least 25% of the outstanding shares of common stock of the Company have the right to request that the Company call a special meeting of stockholders, subject to the requirements and procedures set forth in our bylaws.

Executive Compensation Highlights

•We utilize a compensation model that fosters a culture of collaboration and long-term ownership mindset that encourages our executives to think and act in the best interests of the Company. The spirit of collective ingenuity is paramount to our success.

•We are a values-driven organization with a guiding purpose to empower people to change the world. Our executives are committed to bold thinking, holding themselves and those around them accountable to act with integrity, and realizing positive change in all the work we do. Our executive compensation program is intrinsically tied to our purpose and values. We believe our executives are motivated to act in the best interests of the Company with an emphasis on problem solving, passionate service, and collective ingenuity across markets, customers, and opportunities.

•Together with our Compensation, Culture and People Committee, we are committed to designing a compensation program that aligns the interests of our executives with the long-term interests of our stockholders. This is achieved in part through an executive rewards package that includes a long-term performance based component where a portion of executives' compensation is tied to the achievement of multi-year performance goals. For more details on our compensation program, please see our discussion in the CD&A beginning with the Executive Summary on page 30.

Governance & Oversight of Enterprise Responsibility & Sustainability

We utilize our Enterprise Responsibility & Sustainability (ERS) strategy to enhance resilience, modernize operations, and drive sustainable shareholder value, while continuously supporting our employees, customers, and communities. ERS governance is integrated into our operations, with oversight provided by the Board of Directors through its Nominating and Corporate Governance Committee and the Compensation, Culture and People Committee, which manage key risks, operational priorities, and human capital matters. The day-to-day execution is overseen by an executive-led ERS Committee, chaired by the Chief Legal Officer, and supported by an ERS Council comprising senior leaders from key functional areas and an ERS Function that provides data-driven guidance and insights. These bodies ensure a unified, transparent, and collaborative approach to advancing our enterprise responsibility and sustainability practices.

PROPOSAL 1: ELECTION OF DIRECTORS

Election of Directors

Each of our directors, with the exception of Ms. Barnes, has been nominated for election to the Board for a one-year term, expiring at the 2026 Annual Meeting of Stockholders and until their successors are duly elected and qualified. To be elected in an uncontested election, a nominee must receive a majority of the votes validly cast with respect to that nominee’s election at the annual meeting represented either in person or by proxy at the annual meeting. To be elected in a contested election, a nominee must receive the vote of a plurality of the votes validly cast at the annual meeting represented either in person or by proxy at the annual meeting. Any nominee who is an incumbent director and does not receive a majority of the votes cast in an uncontested election must promptly tender his or her resignation, contingent on the acceptance of that resignation by the Board, to the chair of the Board following certification of the election results.

Board Skills and Expertise

The Nominating and Corporate Governance Committee and the Board believe that each director nominee brings a strong and diverse set of skills and expertise to the Company, as reflected in the chart below, including significant government, public company, financial, and strategic experience, that will strengthen our Board's independent leadership and effectiveness with respect to our business and long-term strategy.

Board skills matrix (proxy) (with RCOB).jpg

Director Nominees

The twelve nominees for election as directors are listed below. If elected, the nominees for election as directors will serve for one-year terms and until their successors are elected and qualify. Unless you instruct us on the proxy card to vote differently, we will vote signed, returned proxies FOR the election of such nominees. If for any reason any nominee cannot or will not serve as a director, we may vote such proxies for the election of a substitute nominee designated by the Board.


Director						Principal Occupation, Business Experience and Other Directorships Held

Joan Lordi C. Amble						Ms. Amble was the Executive Vice President, Finance for the American Express Company from May 2011 to December 2011, and also served as its Executive Vice President and Corporate Comptroller from December 2003 until May 2011. Prior to joining American Express, Ms. Amble served as Chief Operating Officer and Chief Financial Officer of GE Capital Markets, a service business within GE Capital Services, Inc., overseeing securitizations, debt placement, and syndication, as well as structured equity transactions. From 1994 to March 2003, Ms. Amble served as vice president and controller for GE Capital and GE Financial Services. Ms. Amble is the President of JCA Consulting, LLC. Key Skills, Qualifications and Expertise: •Expertise in finance, financial reporting, compliance and controls, and global businesses; •Public company directorship and audit committee experience; •Operating and management experience; •Understanding of government contracting; and •Core business skills, including financial and strategic planning. Other Current Public Company Directorships: • Spire Global, Inc. (NYSE: SPIR) (since August 2022) • Zurich Insurance Group (XSWX: ZURN) (since April 2015) Past Public Company Directorships (within past 5 years): • BuzzFeed, Inc. (NASDAQ: BZFD) (August 2021 – May 2023) — Audit Committee (Chair) • Sirius XM Holdings Inc. (NASDAQ: SIRI) (2008 – June 2021) Private Directorships and Other Memberships: • BuzzFeed, Inc. (June 2023 – December 2023) — Independent Advisor • Société Général, S.A (October 2016 – June 2022) — Independent Advisor • Public Company Accounting Oversight Board (2014 – 2020) — Standing Advisory Group member

Age: 72 Director since: 2012 Independent Committee: •Audit

Debra L. Dial						Ms. Dial is the former Senior Vice President, Chief Accounting Officer, and Controller of AT&T Inc. (NYSE: T), a global telecommunications company. Ms. Dial served as Chief Accounting Officer from 2022 to 2023 and Senior Vice President and Controller from 2016 to 2023. Previously Ms. Dial served as Vice President of Finance for AT&T Capital Management with responsibility for capital allocation, budgeting, and governance, and as Chief Financial Officer for the AT&T Chief Information and Technology Officers. Prior to joining AT&T in 1996, Ms. Dial spent ten years at KPMG in their audit practice. Ms. Dial is a Certified Public Accountant with a BBA in accounting from the McCombs School of Business, University of Texas at Austin. She is a member of the Financial Accounting Standards Advisory Council (FASAC). Key Skills, Qualifications and Expertise: •Public company directorship and audit committee experience; •Operating and management experience; and •Core business skills, including financial and strategic planning. Other Current Public Company Directorships: •Dow Inc. (NYSE: DOW) (since April 2021) •Hubbell Inc. (NYSE: HUBB) (since July 2023)

Age: 64 Director since: January 2025 Independent Committees: •Audit


Director						Principal Occupation, Business Experience and Other Directorships Held

Michèle A. Flournoy						Ms. Flournoy is co-founder and managing partner of WestExec Advisors, a strategic advisory firm founded in 2017. Prior to her position, she served as the Under Secretary of Defense for Policy from 2009 to 2012 and as senior advisor at Boston Consulting Group from 2012 to 2017. She currently serves on the nonprofit board of the Center for a New American Security (CNAS), a bipartisan think tank which she co-founded in 2007 and served as its Chief Executive Officer from 2014 to 2016. Ms. Flournoy has extensive experience in the defense and national security industry and serves as a member of the Council on Foreign Relations and the Aspen Strategy Group and previously served on the Defense Policy Board, the President's Intelligence Advisory Board, the National Security Agency Advisory Board, and the CIA Director's External Advisory Board.

Age: 64 Director since: 2018 Independent Committees: •Compensation, Culture and People •Nominating and Corporate Governance (Chair)						Key Skills, Qualifications and Expertise: • Significant government experience, particularly in national security and defense policies; • Public company directorship and committee experience; and • Core business skills, including financial and strategic planning as well as leading not-for-profit organizations. Other Current Public Company Directorships: •Astra Space, Inc. (NASDAQ: ASTR) (since August 2021) Private Directorships and Other Memberships: •Amida Technology Solutions — Chair of the Board •Microsoft Policy Advisory Board — Member •Harvard University’s Belfer Center for Science and International Affairs — Senior Fellow •Georgia Tech's Sam Nunn School of International Affairs — Non-resident faculty member •CARE USA — Board member •The War Horse — Board member



Mark E. Gaumond						Mr. Gaumond has over 35 years of experience working with senior management and audit committees of public and privately-held companies. He held senior positions with E&Y from 2002 to 2010, retiring from the firm as Senior Vice Chair for the Americas, and previously was a partner with a 27-year career at Andersen LLP. Mr. Gaumond has a BA from Georgetown University and an MBA from New York University. He is a member of the American Institute of Certified Public Accountants. Key Skills, Qualifications and Expertise: •Expertise in finance, financial planning, and compliance and controls; •Public company directorship and audit committee experience; and •Core business skills, including financial and strategic planning. Past Public Company Directorships (within past 5 years): •Rayonier Advanced Materials, Inc. (NYSE: RYAM) (July 2014 — May 2020) Private Directorships and Other Memberships: •First American Funds (January 2016 – March 2024) — Board member, Chairman of the Board (2020 — March 2024) •California Academy of Sciences — Trustee

Age: 74 Director since: 2011 Lead Independent Director Committees: •Executive


Director						Principal Occupation, Business Experience and Other Directorships Held

Ellen Jewett						Ms. Jewett has served as managing partner at Canoe Point Capital LLC, an investment firm focusing on early stage social ventures, since 2015. Prior to that position, from 2010 to 2015, she served as managing director and head of U.S. Government and Infrastructure for BMO Capital Markets. Prior to that, Ms. Jewett spent more than 20 years at Goldman Sachs specializing in airport infrastructure financing, most recently serving as head of the public sector transportation group, and previously as head of the airport finance group. Key Skills, Qualifications and Expertise: • Public company directorship and audit committee experience; • Experience in domestic and international finance and talent management; and • Core business skills, including financial and strategic planning. Other Current Public Company Directorships: •JetBlue (NASDAQ: JBLU) (since 2011) — Governance and Nominating Committee (Chair) Private Directorships and Other Memberships: •Children's Aid (since 2019) — Board member and Treasurer •Wesleyan University — Emerita trustee •The Brearley School — Emerita trustee

Age: 66 Director since: 2018 Independent Committee: •Audit (Chair) •Executive



Arthur E. Johnson						Mr. Johnson retired as Senior Vice President, Corporate Strategic Development of Lockheed Martin Corp. in 2009, a position he held since 1999. Mr. Johnson has over 20 years of senior leadership experience in the information technology, government services, aerospace, and defense businesses. Mr. Johnson brings extensive IT management experience to the Board, having held senior positions at IBM, Loral Corporation, and Lockheed Martin. Key Skills, Qualifications and Expertise: • Public company directorship and audit committee experience; • Operating and management experience; • Understanding of government contracting; and • Core business skills, including financial and strategic planning. Private Directorships and Other Memberships: •Fidelity Investments, Fixed Income and Asset Allocation mutual fund board (2008 — 2023) - Independent Trustee •Eaton Corporation, plc (2009 — 2019) - Board member

Age: 78 Director since: 2011 Independent Committee: •Audit


Director						Principal Occupation, Business Experience and Other Directorships Held

Gretchen W. McClain						Ms. McClain has served as the Chief Executive Officer of J.M. Huber Corporation (a private, family-owned global industrial company) since April 2022. She previously served as an Operating Executive for the Carlyle Group from July 2019 to March 2022. Prior to Carlyle, she was the founding President and Chief Executive Officer of Xylem, Inc. from October 2011 to September 2013. She joined Xylem as the founding CEO in 2011 when it was formed and taken public from a spinoff of the water business of ITT Corporation. She joined ITT in 2005 as the President of its residential and commercial water business, and served as the SVP and President of ITT's commercial businesses from 2008 to 2011. Ms. McClain has served in a number of senior executive positions at Honeywell Aerospace (formerly AlliedSignal), including VP and General Manager of the Business, General Aviation and Helicopters Electronics division, and VP for Engineering and Technology, as well as for Program Management in Honeywell Aerospace's Engines, Systems and Services Division. She also spent nine years with NASA and served as Deputy Associate Administrator for Space Development, where she played a pivotal role in the successful development and launch of the International Space Station Program as Chief Director of the Space Station and Deputy Director for Space Flight. Ms. McClain graduated from the University of Utah with a BS in Mechanical Engineering. Key Skills, Qualifications and Expertise: •Public company directorship and committee experience; •Operating and management experience; and •Core business skills, including financial and strategic planning. Other Current Public Company Directorships: •AMETEK, Inc. (NYSE: AME) (since August 2014) Private Directorships and Other Memberships: •Hennessy Capital Acquisition Corp. IV (2018 — 2020) — Board member •Boart Longyear Limited (November 2015 — August 2019) — Board member •J.M. Huber Corporation (since 2016) — Board member

Age: 62 Director since: 2014 Independent Committees: •Compensation, Culture and People (Chair) •Nominating and Corporate Governance •Executive

Robert C. O’Brien						Mr. O'Brien is the co-founder and chairman of American Global Strategies LLC. Prior to this position he served as the U.S. National Security Advisor from 2019 to 2021. He served as the Special Presidential Envoy for Hostage Affairs from May 2018 to October 2019 and was a presidentially appointed member of the U.S. Cultural Property Advisory Committee from 2008 to 2011. Mr. O'Brien was co-chairman of the U.S. Department of State Public-Private Partnership for Justice Reform in Afghanistan from 2005 to 2009 and served as the U.S. Representative to the 60th session of the UN General Assembly from 2005 to 2006. Additionally, he previously served as the Senior Legal Officer for the UN Security Council from 1996 to 1998. Mr. O'Brien holds a J.D. from the U.C. Berkeley School of Law and a B.A. in political science, cum laude, from UCLA. Key Skills, Qualifications and Expertise: •Significant government experience and strong skills in public policy; and •Core business skills, including financial and strategic planning, as well as leading not-for-profit organizations. Private Directorships and Other Memberships: •President’s Intelligence Advisory Board (PIAB) – Presidentially Appointed Member •The Richard Nixon Foundation – Chair of the Board •Global Taiwan Institute (GTI) Task Force on US-Taiwan Relations – Chairman •Center for Strategic and International Studies (CSIS) Commission on Hostage Taking and Wrongful Detention – Chairman •Exthera Medical Corporation – Advisory Board Member •Citizens Bank – Advisory Board Member •Paradigm Operations LP – Advisory Board Member

Age: 58 Director since: June 2025 Independent Committees: •Compensation, Culture and People •Nominating and Corporate Governance


Director						Principal Occupation, Business Experience and Other Directorships Held



Rory P. Read						Mr. Read has served as President and Chief Executive Officer of Sprinklr since November 2024. He served as Chief Executive Officer of Vonage, a global leader in cloud communications helping businesses accelerate their digital transformation, from July 2020 to March 2024. He also served as Senior Vice President at Ericsson from July 2022 to March 2024, having joined the company as part of Ericsson’s acquisition of Vonage. He has more than four decades of experience leading global technology organizations. Previously, Mr. Read was Chief Operating Executive of Dell Technologies, CEO and President of Dell’s Virtustream, and EVP of Dell Boomi. He also served as Chief Integration Officer and played a lead role in the $67 billion merger of Dell and EMC—the largest tech merger in history. Prior to these roles, he served as CEO, President and Board member of Advanced Micro Devices and Chief Operating Officer and President at Lenovo following 23 years at IBM.

Age: 63 Director since: 2023 Independent Committees: •Compensation, Culture and People •Nominating and Corporate Governance						Key Skills, Qualifications and Expertise: •Operating and management experience; •Understanding of government contracting; and •Core business skills, including financial and strategic planning.



Charles O. Rossotti						Mr. Rossotti has served as a Senior Advisor to The Carlyle Group since June 2003. Prior to this position, Mr. Rossotti served as the Commissioner of the Internal Revenue Service from 1997 to 2002. Mr. Rossotti co-founded American Management Systems, Inc., an international business and information technology consulting firm in 1970, where he served at various times as President, Chief Executive Officer, and Chairman of the Board until 1997. Key Skills, Qualifications and Expertise: •Expertise in finance, financial reporting, compliance and controls, and global businesses; •Public company directorship and audit committee experience; •Operating and management experience; •Understanding of government contracting; and •Core business skills, including financial and strategic planning. Private Directorships and Other Memberships: •Abrigo Corporation (since July 2021) — Board member, Chair of the Audit Committee •Exiger (since March 2024) — Board member •Unison Corporation (April 2020 – August 2022) •Accelerated Learning Inc. (December 2018 – February 2023) — Board member •Novetta Solutions LLC (March 2016 – 2021) — Board member •Coalfire Systems Inc. (November 2015 – July 2019) — Board member •Spark the Journey — Board member and Chair of the Development Committee

Age: 84 Director since: 2008 Independent Committee: •Audit


Director						Principal Occupation, Business Experience and Other Directorships Held



Horacio D. Rozanski						Mr. Rozanski is our Chairman, Chief Executive Officer, and President. A respected business leader, Mr. Rozanski led the transformation of the Company into an advanced technology provider. He joined Booz Allen in 1992 as a consultant to commercial customers, was elected vice president in 1999, and served as our Chief Personnel Officer, Chief Strategy and Talent Officer, Chief Operating Officer, and President before becoming Chief Executive Officer in 2015. Mr. Rozanski became Chairman of our Board of Directors in July 2024. Key Skills, Qualifications and Expertise: •Operating and management experience; •Understanding of government contracting; •Core business skills, including financial and strategic planning; and •Deep understanding of our Company, its history, and culture. Other Current Public Company Directorships: •Marriott International, Inc. (NASDAQ: MAR) (since March 2021) Private Directorships and Other Memberships: •Children’s National Hospital (since 2019) — Board member and Chair (since 2021) •The Economic Club of Washington, DC — Member •Business Roundtable — Member •United States Holocaust Memorial Museum’s Committee on Conscience - Member •Kennedy Center Corporate Fund Board — Vice Chair

Age: 57 Director since: 2014 Committee: •Executive (Chair)



William M. Thornberry						Mr. Thornberry represented the 13th district of Texas in the U.S. House of Representatives from January 1995 until January 2021. He served on the Armed Services Committee throughout his time in Congress, was its Chairman from January 2015 to January 2019, and became its Ranking Member in January 2019. Mr. Thornberry also served on the House Intelligence Committee for 14 years and chaired the Cyber Task Force in 2011. He previously served in the State Department during the Reagan Administration, as staff on Capitol Hill, and practiced law in Amarillo, Texas. Mr. Thornberry’s family has been ranching in Texas since 1881‚ a family business in which he continues to participate. Key Skills, Qualifications and Expertise: •Significant government experience, particularly in national security and defense policies; •Public company directorship experience; •Understanding of government contracting; and •Core business skills, including financial and strategic planning. Private Directorships and Other Memberships: •Fortinet Federal, Inc — Board member •CAE USA — Board member, Chair of the Board

Age: 66 Director since: 2024 Independent Committees: •Compensation, Culture and People •Nominating and Corporate Governance


The Board of Directors recommends a vote FOR each of the director nominees.

NON-CONTINUING DIRECTORS

The one director whose term will not continue after the Annual Meeting is listed below.


Director						Principal Occupation, Business Experience and Other Directorships Held

Melody C. Barnes						Ms. Barnes is the executive director of the Karsh Institute of Democracy at the University of Virginia, where she also serves as the W.L. Lyons Brown Family Director for Policy and Public Engagement at the Democracy Initiative, a professor of practice at the Miller Center of Public Policy, and a distinguished fellow at the School of Law. She is a co-founder of MB Squared Solutions, LLC since 2014. From January 2009 to January 2012, Ms. Barnes served in the White House as Director of the Domestic Policy Council. In this role, she provided policy and strategic advice to President Obama and coordinated the domestic policy-making process for his administration. Before joining the White House, she served as the senior domestic policy advisor for then-Senator Obama’s 2008 presidential campaign. Ms. Barnes was the Executive Vice President for Policy at the Center for American Progress from 2005 to 2008 and Senior Fellow from 2003 to 2005. Prior to her tenure at the Center, Ms. Barnes was a principal in the Raben Group LLC. She also served as Chief Counsel to Senator Edward M. Kennedy on the Senate Judiciary Committee from 1998 to 2003, and General Counsel for Senator Kennedy from 1995 to 1998. Key Skills, Qualifications and Expertise: •Significant government experience and strong skills in public policy; •Public company directorship and committee experience; and •Core business skills, including financial and strategic planning, as well as leading not-for-profit organizations. Other Current Public Company Directorships: •Ventas Inc. (NYSE: VTR) (since 2014) – Nominating and Corporate Governance Committee (Chair) Private Directorships and Other Memberships: •William and Flora Hewlett Foundation (since 2023) — Board member •Thomas Jefferson Foundation (since 2018) — Trustee

Age: 61 Director since: 2015 Independent Committees: •Compensation, Culture and People •Nominating and Corporate Governance

CORPORATE GOVERNANCE AND GENERAL INFORMATION CONCERNING THE BOARD OF DIRECTORS AND ITS COMMITTEES

Our Board of Directors

The Board is responsible for providing governance and oversight over the strategy, risk, operations, and management of the Company. The primary focus of the Board is promoting stockholder value by fostering the long-term success of the Company. The Board is responsible for supporting and overseeing management, to which the Board has delegated the responsibility to manage the day-to-day strategy and operations of the Company.

The Board generally holds four regular meetings per year, and special meetings as necessary. The Board meets in executive session during each regular meeting; non-management directors also typically meet in executive sessions during each regular meeting.

The Board and its committees establish annual calendars of activities to guide the development of their agendas during the year. All directors are invited to propose agenda topics when the annual calendars are established, as well as in advance of each regular Board meeting. In addition, directors are encouraged to raise topics that are not on a meeting agenda or suggest topics for future agendas. Each director is provided written materials in advance of each meeting, and the Board and its committees provide feedback to, and make requests of, management at each of their meetings.

Corporate Governance Guidelines

As noted above, the Board has adopted Corporate Governance Guidelines. The Board and the Nominating and Corporate Governance Committee are responsible for reviewing and amending these guidelines as they deem necessary and appropriate. The Nominating and Corporate Governance Committee is responsible for overseeing the system of corporate governance of the Company. The Corporate Governance Guidelines are available without charge on the Investor Relations portion of our website at investors.boozallen.com.

Codes of Conduct and Ethics

Our website also includes the Company’s Code of Business Ethics and Conduct, which is applicable to our directors and all employees, and the Company's Code of Ethics for Senior Financial Officers, which is applicable to the Company’s Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Controller, and any other persons performing similar functions. Each such code was adopted by the Board and may be accessed without charge on the Investor Relations portion of our website at investors.boozallen.com. We will disclose on the Investor Relations portion of our website any amendments to the Code of Business Ethics and Conduct or Code of Ethics for Senior Financial Officers and any waiver granted to an executive officer or director under these codes. In fiscal year 2025, no such waivers were sought or granted. The information found on the Company's website is not part of this proxy statement nor is it incorporated into any other filings the Company makes with the Securities and Exchange Commission (the "SEC").

Board Meetings and Attendance

Directors are expected to attend each Board meeting, each meeting of the committees on which they serve, and the Annual Meeting of Stockholders. During fiscal year 2025, the Board held seven meetings and acted by written consent. Each of our incumbent directors who served as a director during fiscal year 2025 attended at least 75 percent of the aggregate total number of Board and committee meetings to which they were assigned, and overall attendance was 95 percent. All directors who served at the time of our 2024 Annual Meeting of Stockholders attended that meeting.

Board Leadership Structure

As noted in our Corporate Governance Guidelines, the Board has no policy with respect to the separation of the offices of Chair and Chief Executive Officer. The Board believes that it is important to retain its flexibility to allocate the responsibilities of the offices of the Chair and Chief Executive Officer in any way that is in the best interests of the Company at a given point in time. If the individual elected as Chair is not an independent director, our Corporate Governance Guidelines provide that a lead independent director will be elected annually by a majority of the independent directors upon recommendation of the Nominating and Corporate Governance Committee of the Board.

The Lead Independent Director has specifically delineated responsibilities, which include:

•presiding over executive sessions of the non-management directors and presiding, if the Chair is absent, at Board meetings;

•collaborating with the Chair to set meeting agendas and the annual schedule of meetings;

•providing input to the Chair on the quantity, quality and timeliness of information provided to the board;

•calling and chairing meetings of the independent directors and apprising the Chair of the issues considered;

•serving as the liaison between the independent directors and the Chair and Chief Executive Officer; and

•collaborating with the Audit, Compensation, Culture and People, and Nominating and Corporate Governance Committees on the performance and structure of the Board and its committees, including the performance of individual directors.

At least annually, independent directors also meet in executive session during a regular Board meeting.

The Board regularly reviews the leadership structure to ensure that it continues to meet the needs of the Company and supports the generation of stockholder value, managing risk, and supporting the Company's executive management over the long term. The Board has concluded that it is currently in the best interest of the stockholders for Mr. Rozanski to retain the position of Chairman, Chief Executive Officer, and President. The Board believes that the unified Chair and Chief Executive Officer roles, combined with the robust authority given to the experienced Lead Independent Director, effectively represent the interests of stockholders and enable the Board to discharge appropriate levels of independence, oversight, and responsibility to serve the Company. The Board believes that Mr. Rozanski, with his three decades of experience with the Company and his deep knowledge of the Company’s business and industry, is well qualified for the role of Chairman and that the Board operates effectively and efficiently under his leadership.

The Board exercises strong, independent oversight through frequent executive sessions, wholly independent Board committees, and a tenured Lead Independent Director with clearly delineated and comprehensive duties. The Board believes, given the Company’s unique culture and business model, a Chair that is intimately connected to the firm is essential. Further, the Board believes that presenting a single face to our customers through the combined role is valuable and that unified Board and management leadership best positions the Company to successfully implement its strategy, particularly in the current dynamic and challenging geopolitical and economic environment.

Consistent with the Company’s Corporate Governance Guidelines, in May 2025, a majority of the independent directors, upon recommendation of the Nominating and Corporate Governance Committee, elected Mark E. Gaumond to serve as the Lead Independent Director. Mr. Gaumond has served as the Company's Lead Independent Director since July 2024.

Succession Planning and Talent Reviews

The Board believes that executive management succession planning is one of its most important responsibilities. Accordingly, the Board regularly undertakes executive management succession planning and talent reviews, with support provided by the Compensation, Culture and People Committee. On an annual basis, the Chair leads the Board in an in-depth discussion concerning Chief Executive Officer succession and the Chief Executive Officer leads the Board in a discussion concerning senior management succession. Chief Executive Officer succession is also discussed by the Board in an executive session outside the presence of any management directors. In addition, management updates the Board on key talent indicators, such as recruiting and retention for the overall employee population, throughout the year.

Risk Oversight

Our Board and its committees oversee the Company’s risk management processes, including cybersecurity risks. Through regular briefings from management, the Board remains informed on key risk considerations and mitigation strategies. A cornerstone of this oversight is the Company’s Enterprise Risk Management ("ERM") Program, which systemically identifies and manages enterprise risks that could materially impact operations, reputation, or value.

ERM Program Governance

The ERM Program is overseen by the ERM Steering Committee, which is chaired by the Chief Operating Officer. This committee is responsible for managing the ERM Program and ensuring that enterprise risks are identified, assessed, and mitigated effectively. Comprised of senior executives—including the General Counsel, Chief Information Officer, Chief Information Security Officer, Chief Administrative Officer, Chief Ethics and Compliance Officer, and SVP, Corporate Finance and Investor Relations—the ERM Steering Committee is responsible for:

•Defining and approving the ERM Program framework and risk management structure annually,

•Developing and maintaining the ERM Risk Profile, which prioritizes top enterprise risks,

•Maintaining the Company’s risk appetite across strategic, reputation & brand, operational, financial, and compliance & legal pillars, and

•Assigning risk owners and sponsors to oversee mitigation and monitoring efforts.

Through this structured approach, the ERM Steering Committee ensures that the Company’s risk management framework remains proactive, comprehensive, and aligned with business objectives.

Board Oversight & Committee Responsibilities

The Board maintains risk oversight by:

•Receiving quarterly risk updates, including cybersecurity risks;

•Reviewing an annual enterprise risk assessment conducted by the ERM Program; and

•Engaging in regular briefings from senior management on enterprise and emerging risks and mitigation strategies.

To further strengthen governance, Board committees provide focused oversight in key risk areas:

•Audit Committee – Receives regular updates from the Chief Legal Officer, General Counsel, Chief Ethics and Compliance Officer, Director of Internal Audit, Chief Information Security Officer, and Chief Information Officer on the status of the ethics and compliance program, internal controls over financial reporting, operational compliance areas, and regulatory communications. The Audit Committee also leads the Board’s oversight of cybersecurity risk.

•Compensation, Culture, and People Committee – Oversees human capital management risks, including executive compensation policies and practices, ensuring alignment with the Company’s long-term strategic goals.

•Nominating and Corporate Governance Committee – Oversees risks related to corporate governance and ERS initiatives, ensuring governance practices align with ethical, regulatory, and sustainability standards.

This structured governance framework ensures that risk oversight remains embedded at all levels of the organization.

Annual Board Performance Assessment

The Board and each of the Audit, Compensation, Culture and People, and Nominating and Corporate Governance committees perform an annual assessment of their operations and effectiveness, and set goals for the future. The comments of the directors are compiled and presented, as applicable, to the Chair, the Lead Independent Director, the applicable committee Chair, and the full Board, with further discussion with the appropriate committee as needed. The key matters to be addressed are identified, and these matters become part of future agendas for the Board and its committees.

Board Independence

Twelve of our thirteen current directors are independent under our Corporate Governance Guidelines and applicable New York Stock Exchange ("NYSE") listing standards. For a director to be considered independent, the Board must determine, after consideration of all relevant facts and circumstances, that the director has no material relationship with the Company directly or as a partner, stockholder, or officer of an organization that has a relationship with the Company. The independence criteria adopted by the Board are set forth in the Company's Corporate Governance Guidelines.

The Board has determined that Messrs. Gaumond, Johnson, O'Brien, Read, Rossotti, and Thornberry, and Mses. Amble, Barnes, Dial, Flournoy, Jewett, and McClain are independent under the independence criteria for directors established by the NYSE and the independence criteria adopted by the Board. As a result, we currently have a majority of independent directors and satisfy the applicable rule of the NYSE. Mr. Rozanski is an employee of the Company and is not independent under the NYSE listing standards or our Corporate Governance Guidelines, which can be found in the Investor Relations portion of our website at investors.boozallen.com.

Selection of Nominees for Election to the Board

The Nominating and Corporate Governance Committee recommends to the Board appropriate criteria for the selection of new directors based on the strategic needs of the Company and the Board, and periodically reviews the criteria adopted by the Board and, if deemed desirable, recommends to the Board changes to such criteria. The Board seeks members from a variety of professional backgrounds who combine a broad spectrum of experience and expertise with a reputation for integrity. Directors should have experience in positions with a high degree of responsibility, be, or have been, leaders in the companies or institutions with which they are, or were, affiliated, and be selected based upon the contributions they can make. Exceptional candidates who meet alternative criteria may also be considered.

Board Tenure

We believe that a Board with a range of tenures is important and directors with many years of service provide the Board with a deep knowledge of our Company, while newer directors lend fresh perspectives. The chart below reflects the Board tenure of our directors, which on average is approximately 8.2 years.

Board Tenure

Process for Stockholders to Recommend Director Nominees

Stockholders wishing to nominate a candidate for director must provide written notice, in care of the Secretary, to 8283 Greensboro Drive, McLean, Virginia 22102, not fewer than 90 days nor more than 120 days prior to the first anniversary of the preceding year's annual meeting. Our bylaws set forth the requirements for direct nomination of an individual by a stockholder for election to the Board.

There is no difference in the manner in which the Nominating and Corporate Governance Committee evaluates a nominee for director designated by our Chief Executive Officer or recommended by a stockholder.

Director Orientation and Continuing Education

New directors are provided a multi-phase orientation generally timed to coincide with our Board meetings as part of our effort to integrate them into their role as directors and familiarize them with the Company. Orientation sessions are led by members of management and are focused on various elements of our business strategy, service offerings, internal business operations, and corporate governance, among other areas. During the course of the year, representatives of management brief the Board on topics designed to provide directors a deeper understanding of various aspects of our business, such as applicable legal developments, ethics and compliance programs, and the evolving regulatory environment. In addition, the Board holds an annual business strategy session with management. Directors are also encouraged to participate in continuing education programs to better understand and execute their duties and responsibilities.

Communications with the Board

Stockholders, or other interested third parties, who wish to contact our Board may send written correspondence, in care of the Secretary, to 8283 Greensboro Drive, McLean, Virginia 22102. Communications may be addressed to an individual director, to the non-management directors as a group, or to the Board as a whole, marked as confidential or otherwise. Communications not submitted confidentially, which are addressed to directors that discuss business or other matters relevant to the activities of our Board, will be preliminarily reviewed by the office of the Secretary and then distributed either in summary form or by delivering a copy of the communication. Communications marked as confidential will be distributed, without review by the office of the Secretary, to the director, or group of directors, to whom they are addressed. With respect to other correspondence received by the Company that is addressed to one or more directors, the Board has requested that the following items not be distributed to directors because they generally fall into the purview of management, rather than the Board: junk mail and mass mailings, service complaints and inquiries, résumés and other forms of job inquiries, solicitations for charitable donations, surveys, business solicitations, and advertisements.

Board Committees

Our Board has four standing committees: an Executive Committee, an Audit Committee, a Compensation, Culture and People Committee, and a Nominating and Corporate Governance Committee. The charter of each committee is available without charge on the Investor Relations portion of our website at investors.boozallen.com.

The following chart identifies the current members and chair of each standing committee, as well as related information.

The following is a brief description of our committees.

The Executive Committee

Our Executive Committee is responsible, among its other duties and responsibilities, for assisting our Board in fulfilling its responsibilities. Our Executive Committee is responsible for approving certain extraordinary corporate actions. The current members of our Executive Committee are Messrs. Gaumond and Rozanski and Mses. Jewett and McClain. The Executive Committee did not meet or act by written consent during fiscal year 2025.

The Audit Committee

Our Audit Committee is responsible, among its other duties and responsibilities, for overseeing our accounting and financial reporting processes, the audits of our financial statements, the qualifications and independence of our independent registered public accounting firm, the effectiveness of our internal control over financial reporting, and the performance of our internal audit function and independent registered public accounting firm. Our Audit Committee reviews and assesses the qualitative aspects of our financial reporting, our processes to manage business and financial risks, and our compliance with significant applicable legal, ethical, and regulatory requirements. Our Audit Committee is directly responsible for the appointment, compensation, retention, and oversight of our independent registered public accounting firm.

The members of our Audit Committee are Mses. Amble, Dial and Jewett (Chair) and Messrs. Johnson and Rossotti, each of whom is an independent director as required by NYSE listing standards and Rule 10A-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Board has determined that each member of our Audit Committee is financially literate and that Mr. Rossotti and Mses. Amble, Dial, and Jewett are each an “audit committee financial expert” as such term is defined under Item 407(d)(5) of Regulation S-K promulgated under the Securities Act of 1933, as amended (the "Securities Act").

The Audit Committee met four times during fiscal year 2025.

The Compensation, Culture and People Committee

Our Compensation, Culture and People Committee is responsible, among its other duties and responsibilities, for reviewing and approving all forms of compensation to be provided to the executives and directors of our Company and its subsidiaries (including the Chief Executive Officer), establishing and reviewing the general compensation philosophy of our Company and its subsidiaries, reviewing, approving, and overseeing the administration of the employee benefits plans of our Company and its subsidiaries, assisting the Board in overseeing succession planning of the Chief Executive Officer and key management positions, and overseeing programmatic matters relating to human capital management and culture.

The current members of our Compensation, Culture and People Committee are Mses. Barnes, Flournoy, and McClain (Chair) and Messrs. O'Brien, Read and Thornberry, each of whom is an independent director as required by NYSE listing standards. The Compensation, Culture and People Committee charter, a copy of which is available on our website, www.boozallen.com, requires that all members of the Compensation, Culture and People Committee must satisfy the requirements of “non-employee director” for purposes of Rule 16b-3 under the Exchange Act. Each of the members of the Compensation, Culture and People Committee currently satisfies these requirements. On May 27, 2025, Ms. Barnes notified the Board of her intention to not stand for re-election at the 2025 Annual Meeting of Stockholders and resigned from her position on the Compensation, Culture and People Committee effective as of the Annual Meeting.

The Compensation, Culture and People Committee has the authority to delegate any of its responsibilities to subcommittees as the Compensation, Culture and People Committee may deem appropriate, provided that the subcommittees are composed entirely of directors satisfying the independence standards then applicable to the Compensation, Culture and People Committee generally.

The Compensation, Culture and People Committee has not engaged a compensation consultant; however, the Compensation, Culture and People Committee is briefed by management, which consults with Pay Governance LLC, or Pay Governance, which replaced Korn Ferry in November 2024. The aggregate fees paid to Pay Governance for fiscal year 2025 were $56,445, all of which were related to executive compensation services. The aggregate fees paid to Korn Ferry for fiscal year 2025 were $667,452, of which $167,452 were related to executive compensation services. The Compensation, Culture and People Committee assessed the independence of Pay Governance and Korn Ferry and concluded that neither Pay Governance's nor Korn Ferry's work for the Company raised any conflicts of interest. See section "Setting Executive Compensation and Peer Group" of the Compensation Discussion and Analysis for more details of services provided during the fiscal year by both Korn Ferry and Pay Governance.

Each of the members of our Leadership Team participates in the discussion and consideration of compensation to be awarded to the executives in their reporting chain. Our Leadership Team does not participate in the discussions or provide any recommendations to the Compensation, Culture and People Committee regarding their own compensation. See “Compensation Discussion and Analysis—Setting Executive Compensation and Peer Group."

The Compensation, Culture and People Committee met five times during fiscal year 2025.

The Nominating and Corporate Governance Committee

Our Nominating and Corporate Governance Committee is responsible for, among its other duties and responsibilities, identifying and recommending candidates to the Board for election to our Board (including candidates proposed by stockholders), reviewing the composition of the Board and its committees, developing and recommending to the Board corporate governance guidelines, overseeing Board and Board committee evaluations, and overseeing practices related to corporate governance, corporate citizenship, and ERS matters.

The current members of our Nominating and Corporate Governance Committee are Mses. Barnes, Flournoy (Chair) and McClain and Messrs. O'Brien, Read and Thornberry, each of whom is an independent director as required by NYSE listing standards. On May 27, 2025, Ms. Barnes notified the Board of her intention to not stand for re-election at the 2025 Annual Meeting of Stockholders and resigned from her position on the Nominating and Corporate Governance Committee effective as of the Annual Meeting.

The Nominating and Corporate Governance Committee met four times during fiscal year 2025.

Director Compensation

Directors who are employed by us do not receive any additional compensation for their services as directors. For non-employee directors, on an annual basis, the Chief People Officer, with the assistance of our outside compensation consultant, performs a comprehensive review of director compensation and makes recommendations to the Compensation, Culture and People Committee regarding proposed changes. In July 2024, the Compensation, Culture and People Committee reviewed director compensation data for the peer group used for benchmarking executive compensation and the general market. Based on that review, the Compensation, Culture and People Committee approved a $25,000 increase in the annual equity award. Additionally, the Compensation, Culture and People Committee approved a $50,000 additional retainer for the Lead Independent Director, and a $5,000 increase in the additional retainer for each of the Compensation, Culture and People Committee and Nominating and Corporate Governance chairs. The changes to the compensation levels for directors apply for their service from August 2024 to July 2025.

Director compensation included the following:


Component						Annual Amount
Annual Equity Award						$225,000
Annual Board Retainer						$120,000
Lead Independent Director Additional Retainer						$50,000
Audit Committee Chair Additional Retainer						$30,000
Compensation, Culture and People Committee Chair Additional Retainer						$25,000
Nominating and Corporate Governance Committee Chair Additional Retainer						$20,000

The annual equity awards to our directors are granted in the form of restricted stock under our 2023 Equity Incentive Plan (the "Equity Incentive Plan"). Generally these grants occur in August following our annual meeting of stockholders and half of the annual award vests on January 31 of the following year, and the other half vests on July 31 following the first vesting date. The annual retainer and any additional payments for service as a chair are generally paid in cash, unless a director elects to receive all or a portion of such payments in the form of restricted stock. Our directors do not receive additional fees for attending Board or committee meetings.

The following table shows the compensation earned by or paid to our non-employee directors in fiscal year 2025:

Director Compensation Table


Name	Fees Earned ($)	Stock Awards ($)(1)(13)	Total ($)(14)
Joan Lordi C. Amble	120,000(2)	225,081(2)	345,081
Melody C. Barnes	120,000(3)	225,003(3)	345,003
Debra L. Dial	69,370(4)	130,070(4)	199,440
Michèle A. Flournoy	140,000(5)	225,094(5)	365,094
Mark E. Gaumond	185,000(6)	225,036(6)	410,036
Ellen Jewett	142,438(7)	225,003(7)	367,442
Arthur E. Johnson	120,000(8)	225,003(8)	345,003
Gretchen W. McClain	145,000(9)	225,003(9)	370,003
Rory P. Read	120,000(10)	225,081(10)	345,081
Charles O. Rossotti	120,000(11)	225,081(11)	345,081
William M. Thornberry	120,000(12)	225,003(12)	345,003

(1)This column represents the grant date fair value of the stock awards granted to our directors in fiscal year 2025. Where the stock awards were the result of voluntary elections to receive cash retainers in stock, the value reflected in this column represents only the excess of the fair market value of the stock awards over the cash retainer amount paid if in the form of stock. The aggregate fair value of the awards was computed in accordance with FASB ASC Topic 718 using the valuation methodology and assumptions set forth in Note 18 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, which are incorporated by reference herein, modified to exclude any forfeiture

assumptions related to service-based vesting conditions. The amounts in this column do not reflect the value, if any, that ultimately may be realized by the director.

(2)Ms. Amble elected to receive her annual retainer in the form of restricted stock, and was granted a total of 2,414 shares of restricted stock for her annual equity grant and in lieu of a portion of the annual retainer. The grant date fair market value of the shares was $345,081, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(3)Ms. Barnes elected to receive her annual retainer in the form of cash, and was granted a total of 1,574 shares of restricted stock for her annual equity grant. The grant date fair market value of the shares was $225,003, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(4)Ms. Dial elected to receive her annual retainer in the form of cash and was granted a total of 1,009 shares of restricted stock for her annual equity grant. The grant date fair market value of the shares was $130,070, based on the $128.91 closing price of our stock on the January 28, 2025 grant date.

(5)Ms. Flournoy elected to receive her annual retainer and her additional payment for service as the chair of the Nominating and Corporate Governance Committee in the form of restricted stock, and was granted a total of 2,554 shares of restricted stock for her annual equity grant and in lieu of (i) her annual retainer and (ii) $20,000 for the chair retainer. The grant date fair market value of the shares was $365,094, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(6)Mr. Gaumond elected to receive his annual retainer and his additional payment of $15,000 for services as the chair of the Audit Committee in the form of cash. He elected his additional payment for service as the Lead Independent Director in the form of restricted stock. He was granted a total of 1,924 shares of restricted stock for his annual equity grant and in lieu of $50,000 for the Lead Independent Director retainer. The grant date fair market value of the shares was $275,036, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(7)Ms. Jewett was elected chair of the Audit Committee effective November 1, 2024. Ms. Jewett elected to receive her annual retainer and her additional payment of $22,438 for services as the chair of the Audit Committee in the form of cash. She was granted a total of 1,574 shares of restricted stock for her annual equity grant. The grant date fair market value of the shares was $225,003, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(8)Mr. Johnson elected to receive his annual retainer in the form of cash, and was granted a total of 1,574 shares of restricted stock for his annual equity grant. The grant date fair market value of the shares was $225,003, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(9)Ms. McClain elected to receive her annual retainer and her additional payment of $25,000 for service as the chair of the Compensation, Culture and People Committee in the form of cash, and was granted a total 1,574 shares of restricted stock for her annual equity grant. The grant date fair market value of the shares was $225,003, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(10)Mr. Read elected to receive his annual retainer in the form of restricted stock, and was granted a total of 2,414 shares of restricted stock for his annual equity grant and in lieu of the annual retainer. The grant date fair market value of the shares was $345,081, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(11)Mr. Rossotti elected to receive his annual retainer in the form of restricted stock, and was granted a total of 2,414 shares of restricted stock for his annual equity grant and in lieu of the annual retainer. The grant date fair market value of the shares was $345,081, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(12)Mr. Thornberry elected to receive his annual retainer in the form of cash, and was granted 1,574 shares of restricted stock for his annual equity grant. The grant date fair market value of the shares was $225,003, based on the $142.95 closing price of our stock on the August 1, 2024 grant date.

(13)The following table sets forth the aggregate number of equity awards outstanding at the end of fiscal year 2025.

(14)Mr. O'Brien is not featured in the preceding table because he was elected to the Board effective June 9, 2025, following the end of fiscal year 2025.

Equity Awards for Service as a Director


Name									Unvested Restricted Stock (a)
Joan Lordi C. Amble									1,207
Melody C. Barnes									787
Debra L. Dial									505
Michèle A. Flournoy									1,277
Mark E. Gaumond									962
Ellen Jewett									787
Arthur E. Johnson									787
Gretchen W. McClain									787
Rory P. Read									1,207
Charles O. Rossotti									1,207
William M. Thornberry									787

(a)The shares of restricted stock reported in this column vest on July 31, 2025.

Director Ownership Guidelines

Equity ownership guidelines for all of our non-employee directors are in place to further align their interests to those of our stockholders. Each of our non-employee directors has five years from the date of commencement of his/her service on the Board to achieve equity ownership with a value equivalent to five times his/her annual retainer. In calculating a director’s ownership, Class A common stock, vested in-the-money options, and vested and unvested restricted stock issued under the Equity Incentive Plan will be considered owned by the non-employee director. Each of our directors who has served on the Board for five years or more has regularly exceeded and currently exceeds the equity ownership guidelines. For a description of the guidelines applicable to executive officers, see our CD&A beginning on page 29.

Insider Trading Policy and Policy on Hedging, Short Sales, and Speculative Transactions

The Company has an Insider Trading Policy, which governs the purchase, sale and other dispositions of its securities by employees, officers, directors, subsidiaries, and affiliates of the Company, as well as their immediate family members and other persons living in their households. The Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules and regulations and any listing standards applicable to the Company.

Under the Company's Insider Trading Policy, the Company’s personnel are prohibited from directly or indirectly buying, selling or gifting securities of the Company while in possession of material non-public information concerning the Company or its securities, except in the limited circumstances described in the policy. Additionally, the Company’s personnel are prohibited from engaging in (i) short sales of securities of the Company, (ii) transactions in puts, calls, or other derivative securities with respect to securities of the Company, (iii) hedging transactions with respect to securities of the Company, (iv) holding securities of the Company in a margin account, and (v) pledging securities of the Company as collateral for a loan.

COMPENSATION COMMITTEE INTERLOCKS

AND INSIDER PARTICIPATION

The following individuals served on our Compensation, Culture and People Committee during fiscal year 2025: Mses. Barnes, Flournoy, and McClain and Messrs. Read and Thornberry. No member of our Compensation, Culture and People Committee currently is, or has been, an officer or employee of the Company. During fiscal year 2025, none of our executive officers served as a member of the Board or compensation committee (or other board committee performing equivalent functions) of any other entity that has one or more of its executive officers serving as a member of our Board or Compensation, Culture and People Committee.

SECURITY OWNERSHIP INFORMATION

Security Ownership of Directors and Executive Officers

The following table indicates information as of May 16, 2025 regarding the beneficial ownership of our Class A common stock by each of our directors, each of the named executive officers, and all of our directors and executive officers as a group.

The percentages shown are based on 124,187,634 shares of Class A common stock outstanding as of May 16, 2025. Class A common stock is entitled to one vote per share on all matters voted on by our stockholders.

The amounts and percentages owned are reported on the basis of the SEC’s rules governing the determination of beneficial ownership of securities. The SEC’s rules generally attribute beneficial ownership of securities to each person who possesses, either solely or shared with others, the voting power or investment power, which includes the power to dispose of those securities. The rules also treat as outstanding all shares of capital stock that a person would receive upon exercise of stock options or warrants held by that person that are immediately exercisable or exercisable within 60 days. These shares are deemed to be outstanding and to be beneficially owned by the person holding those options for the purpose of computing the number of shares beneficially owned and the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Under these rules, one or more persons may be a deemed beneficial owner of the same securities and a person may be deemed a beneficial owner of securities to which such person has no economic interest. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.

Name

Shares Beneficially Owned

Percentage of Class

Directors and nominees

Joan Lordi C. Amble

56,860

Melody C. Barnes

18,123

Debra L. Dial

1,009

Michèle A. Flournoy

17,559

Mark E. Gaumond

60,506

Ellen Jewett

14,071

Arthur E. Johnson

39,361

Gretchen W. McClain

29,826

Robert C. O'Brien

Rory P. Read

6,788

Charles O. Rossotti

14,087

Horacio D. Rozanski

583,601

William M. Thornberry

2,025

Other named executive officers

Matthew Calderone

59,469(1)

Kristine Martin Anderson

129,836(2)

Richard Crowe

49,304(3)

Nancy J. Laben

45,325(4)

All directors and executive officers as a group (20 persons)(5)(6)

1,127,750

0.91%

* Represents beneficial ownership of less than 1%.

(1)Includes 32,732 shares that Mr. Calderone has the right to acquire through the exercise of options.

(2)Includes 49,858 shares that Ms. Anderson has the right to acquire through the exercise of options.

(3)Includes 26,181 shares that Mr. Crowe has the right to acquire through the exercise of options.

(4)Includes 23,193 shares that Ms. Laben has the right to acquire through the exercise of options.

(5)Includes 201,668 shares that the directors and executive officers, in aggregate, have the right to acquire through the exercise of options.

(6)Mr. O'Brien did not own shares of our Class A common stock as of May 16, 2025 because he was elected to the Board effective June 9, 2025, following the end of fiscal year 2025.

Security Ownership of Certain Beneficial Owners

The following table sets forth information as to any person known to us to be the beneficial owner of more than 5% of our Class A common stock.


Name and Address	Shares Beneficially Owned	Percentage of Class
The Vanguard Group (1) 100 Vanguard Boulevard Malvern, Pennsylvania 19355	13,228,775	10.65%
Blackrock, Inc. (2) 50 Hudson Yards New York, New York 10001	9,634,129	7.76%
T. Rowe Price Associates, Inc. (3) 100 E. Pratt Street Baltimore, Maryland 21202	9,032,406	7.27%

(1)The Vanguard Group has filed with the SEC a Schedule 13G/A dated February 13, 2024, which reports the beneficial ownership of 13,228,775 shares of Class A common stock by it as of December 29, 2023. As reported in the Schedule 13G/A, The Vanguard Group had sole voting power with respect to 0 shares of our Class A common stock, sole dispositive power with respect to 13,055,540 shares of our Class A common stock, shared voting power with respect to 81,202 shares of our Class A common stock, and shared dispositive power with respect to 173,235 shares of our Class A common stock.

(2)Blackrock, Inc. has filed with the SEC a Schedule 13G/A dated January 26, 2024, which reports the beneficial ownership of 9,634,129 shares of Class A common stock by it as of December 31, 2023. As reported in the Schedule 13G/A, Blackrock, Inc. had sole voting power with respect to 8,970,784 shares of our Class A common stock, sole dispositive power with respect to 9,634,129 shares of our Class A common stock, shared voting power with respect to 0 shares of our Class A common stock, and shared dispositive power with respect to 0 shares of our Class A common stock.

(3)T. Rowe Price Associates, Inc. has filed with the SEC a Schedule 13G/A dated February 14, 2025, which reports the beneficial ownership of 7,343,949 shares of Class A common stock by it as of December 31, 2024. As reported in the Schedule 13G/A, T. Rowe Price Associates, Inc. had sole voting power with respect to 7,028,770 shares of our Class A common stock, sole dispositive power with respect to 7,343,911 shares of our Class A common stock, shared voting power with respect to 0 shares of our Class A common stock, and shared dispositive power with respect to 0 shares of our Class A common stock.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Policies and Procedures for Related Person Transactions

We adopted a written related person transactions policy pursuant to which related persons, namely our executive officers, directors, and principal stockholders, and their immediate family members, are not permitted to enter into certain transactions, or materially modify or amend an ongoing transaction, with us, in which the amount involved exceeds $120,000, without the consent of our Audit Committee or any other body of the Board of Directors comprised solely of independent directors. Any request for us to enter into or materially modify or amend certain such transactions is required to be presented to our Audit Committee for review, consideration, and approval. All of our directors and executive officers are required to report to our Secretary any such proposed related person transaction, who is required to provide notice of such proposed related person transaction to the Audit Committee. In approving or rejecting the proposed transaction, our Audit Committee will take into account, among other factors it deems appropriate, whether the proposed related person transaction is on terms at least as favorable as terms generally available to an unaffiliated third party under the same or similar circumstances, the extent of the related person’s interest in the transaction and, if applicable, the impact on a director’s independence. Under the policy, if we should discover related person transactions that have not been approved, our Audit Committee will be notified and will determine the appropriate action, including ratification, rescission, or amendment of the transaction.

Related Person Transactions

Indemnification Agreements

We have entered into indemnification agreements with each of our directors and executive officers pursuant to which we have agreed to indemnify such individuals against certain liabilities arising out of service as a director or officer of the Company and its subsidiaries. The indemnification agreements provide our directors and executive officers with contractual rights to the indemnification and expense advancement rights provided under our bylaws, as well as contractual rights to additional indemnification as provided in the indemnification agreements.

Other Relationships

Bryan E. Shrader, a Senior Vice President at the Company, is the son of Dr. Ralph Shrader, our former Chief Executive Officer and former Chair of the Board. In fiscal year 2025, Mr. Shrader received $353,125 in base salary, a cash bonus of $320,000, and retirement contributions of $43,391. He received a grant of 908 time-based restricted stock units with a grant date fair value of $138,343 and a grant of 303 performance-based restricted stock units with a grant date fair value of $46,165. Mr. Shrader also participates in the Company’s other benefit programs on the same basis as other employees at the same level.

Emily Pfeifer, a Senior Consultant at the Company, is the daughter of Tom Pfeifer, an Executive Vice President and President of the Company's National Security sector. In fiscal year 2025, Ms. Pfeifer received $119,435 in base salary and retirement contributions of $7,031. Ms. Pfeifer also participates in the Company’s other benefit programs on the same basis as other employees at the same level.

Quinn Calderone, a Senior Consultant at the Company, is the son of Matt Calderone, an Executive Vice President and Chief Financial Officer. In fiscal year 2025, Mr. Calderone received $92,557 in base salary and retirement contributions of $5,298, and $300 in awards. Mr. Calderone also participates in the Company’s other benefit programs on the same basis as other employees at the same level.

COMPENSATION DISCUSSION AND ANALYSIS

The Compensation Discussion and Analysis (CD&A), together with the compensation tables and related disclosures, provides a narrative of our executive compensation philosophy and programs as reviewed and determined by the Compensation, Culture and People Committee of the Board of Directors.

At Booz Allen, our purpose is to empower people to change the world. Our leadership philosophy and partnership culture are foundational to how we drive transformation and guide our people to solve our customers' toughest challenges.

Our executive compensation strategy is uniquely designed to:

•Deliver competitive compensation tied to long-term stockholder value creation;

•Attract and retain top talent from across the global marketplace who will continue to propel us forward for the future;

•Motivate and reward executives with exceptional ability to meet and exceed the demands of our customers;

•Infuse an ownership mindset to build sustainable growth and value; and

•Reinforce our partnership-style culture which differentiates our ability to come to market as an institution rather than as individuals, create alignment on our strategy, priorities and associated investments, and encourage rapid and efficient deployment of our people across customers and opportunities.

The tenure of our executives is a testament to the team's long-standing commitment to the Company and its long-term business goals. Our named executive officers for fiscal year 2025 were:

Horacio D. Rozanski

Matthew A. Calderone

Kristine Martin Anderson

Richard C. Crowe

Nancy J. Laben

Chairman, Chief Executive Officer, and President

Executive Vice President, Chief Financial Officer

Executive Vice President, Chief Operating Officer

Executive Vice President,
President of Civilian Services Sector

Executive Vice President,
Chief Legal Officer*

Tenure as Chairman: 1 year
Tenure as CEO: 10 years
Executive Tenure: 25 years
Total Tenure: 32 years

Tenure as CFO: 2 years
Executive Tenure: 13 years
Total Tenure: 22 years

Tenure as COO: 2 years
Executive Tenure: 15 years
Total Tenure: 19 years

Tenure as Civil Sector President: 2 years
Executive Tenure: 11 years
Total Tenure: 20 years

Tenure as CLO: 11 years
Executive Tenure: 11 years
Total Tenure: 11 years

*Ms. Laben is currently taking a personal leave of absence.

Executive Summary

Fiscal Year 2025 Company Performance and Highlights

Net Income

Adj. EBITDA*

Net Income ($ millions)

Adj. EBITDA ($ millions)

*Adjusted EBITDA may differ from similarly titled measures presented by other companies in our industry and is not a recognized measure under U.S. Generally Accepted Accounting Principles, or GAAP. See Appendix A to this proxy statement for a reconciliation of such measure against the most directly comparable financial measure calculated and presented in accordance with GAAP.

In fiscal year 2025, our staff and leaders led the Company to deliver strong performance for fiscal year revenue and earnings, with fiscal year 2025 marking the tenth consecutive year of top-line revenue growth. The Company also delivered significant returns to our stockholders through the payment of regular dividends and share repurchases. In fiscal year 2025:

•Full year revenue increased 12.4% to $12.0 billion.

•Net income increased 54.3% to $935.0 million.

•Adjusted EBITDA increased 11.9% to $1,315.0 million.

•We declared and paid $268.3 million in recurring dividends to stockholders—three regular dividends of $0.51 per share and one regular dividend of $0.55 per share.

•The Board increased the quarterly dividend by 8% for performance in the third quarter of fiscal year 2025, payable in the fourth quarter of fiscal year 2025. The total dividends paid in fiscal year 2025 grew 8% compared to fiscal year 2024.

•We allocated $37.2 million to strategic investments.

•We repurchased 5.6 million shares for $763.6 million.

•The Board of Directors approved, on January 28, 2025, an additional increase to our share repurchase authorization of $500.0 million, for a total capacity of $3,585.0 million under the share repurchase program. As of March 31, 2025, the Company had approximately $744.7 million of unused capacity to repurchase shares of common stock under the share repurchase program.

Compensation Philosophy

We are a values-driven organization where our partnership culture motivates our executives, who we define as our named executive officers, Executive Vice Presidents, and Senior Vice Presidents, to consistently act in the best interests of the Company. Our executive compensation program is intrinsically tied to our purpose and values.

Our Philosophy

What Our Philosophy Achieves

Guides executives to live the Company's purpose and values in their customer work and internal interactions

Empowers executives to think and act in the best interests of the Company

Aligns executives' compensation with Company performance, strategic objectives, and the creation of long-term sustainable stockholder value

Focuses on optimizing stockholder value and fostering an ownership culture

Attracts, motivates, and retains executives of exceptional ability to meet and exceed the demands of our customers

Engages and incentivizes our executives to effectively execute our business strategy

Creates appropriate rewards and penalties for exceeding or falling short of Company-level performance targets

Creates and enables agility within our leadership and the Company overall, allowing us to quickly adjust, align, and advance in an ever-changing global marketplace

Key Executive Compensation Practices

To ensure strong corporate governance, our compensation program incorporates the following key practices:

At Booz Allen, We:

At Booz Allen, We Don't:

Require our executives and directors to satisfy meaningful stock ownership requirements

Reprice underwater stock options

Maintain a clawback policy and include additional compensation recovery provisions in our incentive plans

Offer individual supplemental executive retirement plans

Perform annual review of appropriate peer group to benchmark executive compensation

Grant discounted stock options

Conduct annual risk assessment of incentive-based compensation to identify any issues that could have a material, adverse impact on the Company

Provide tax gross-ups on golden parachute payments for CEO or other officers following a change in control

Review on a regular basis our executive talent, performance, deployments, and succession

Allow for change in control agreements for named executive officers

Align executive pay with short- and long-term performance

Allow employees or directors to engage in hedging transactions or pledging of our shares

Hold annual advisory vote on executive compensation

Provide single-trigger vesting in the event of a change in control

Setting Executive Compensation and Peer Group

We evaluate our named executive officers' compensation relative to the compensation of publicly traded peer companies that are similar in size, industry, and operations. The Compensation, Culture and People Committee reviews the peer group regularly and adjusts as necessary due to changes at a peer company's operations or changes in comparability (e.g., due to bankruptcy or mergers and acquisitions) to the Company. The peer group is used by the Compensation, Culture and People Committee as a point of reference in determining pay within a competitive range without targeting a specific benchmark when making executive pay decisions.

For setting fiscal year 2025 executive compensation, the Compensation, Culture and People Committee requested that our outside compensation consultant, who at the time was Korn Ferry, perform a comprehensive review of the peer companies used for evaluating our named executive officers' compensation. Korn Ferry evaluated companies that are similar in size, industry, and operations, using specific review criteria, as described below:

•Company size: Organizations with revenues approximately 0.33x to 3.00x of our revenue, with peer median revenue approximating Company revenue, and with flexibility outside of this range to accommodate organizations that are a good match from a business perspective.

•Industry: Government services organizations in information technology consulting and other services industries, such as cyber, data processing and outsourced services, and the aerospace and defense industries, as well as other comparable organizations that our Investor Relations department tracks and/or that benchmark to our Company.

As a result of this review, the Compensation, Culture and People Committee approved the peer group set forth below for benchmarking and setting compensation of our named executive officers for fiscal year 2025, the same peer group referred to for benchmarking and setting compensation for our named executive officers in fiscal year 2024.


Fiscal Year 2025 Peer Group
- Akamai Technologies, Inc. (AKAM) - CACI International, Inc. (CACI) - CGI Group, Inc. (GIB) - Cognizant Technology Solutions (CTSH) - Conduent Incorporated (CNDT) - DXC Technology (DXC) - EPAM Systems, Inc. (EPAM) - FISERV, Inc. (FI)			- FTI Consulting, Inc. (FCN) - Jacobs Engineering (J) - KBR Inc. (KBR) - L3Harris Technologies, Inc. (LHX) - Leidos Holdings, Inc. (LDOS) - Maximus, Inc. (MMS) - Parsons Corporation (PSN) - Science Applications International Corporation (SAIC)

The Compensation, Culture and People Committee established fiscal year 2025 target compensation for the named executive officers by taking into consideration the peer group benchmarking analysis and input from Korn Ferry, along with feedback from the CEO (in the case of named executive officers who are direct reports to the CEO), and the Committee's collective judgment and discretion. The target executive compensation includes the fiscal year salary amount, target short-term annual cash incentive, and long-term equity incentive. Additional information on each of these items can be found below under "Compensation Elements."

In fiscal year 2025, Korn Ferry was also engaged to:

•Review and provide advice on our Compensation Discussion & Analysis;

•Participate in the compensation risk assessment;

•Perform benchmarking and analysis of our Board of Directors' compensation; and

•Provide general market intelligence for setting short-term and long-term performance metrics and associated goals in the Annual Incentive Plan and the Equity Incentive Plan.

In consultation with the Compensation, Culture and People Committee, the Company made a decision in the latter part of fiscal year 2025 to engage a new executive compensation consultant, Pay Governance. Pay Governance provided advice in fiscal year 2025 related to the following matters:

• Executive compensation strategy, peer selection insight, and market alignment, with respect to fiscal year 2026;

• Benchmarking and analysis of our CEO and other named executive officers' fiscal year 2026 compensation; and

• General market intelligence for setting short-term and long-term performance metrics and associated goals in the Annual Incentive Plan and the Equity Incentive Plan.

The Compensation, Culture and People Committee considers peer group benchmarking and other market compensation data as critical inputs but not the sole factors in the overall assessment of competitiveness of our executive compensation. The Compensation, Culture and People Committee also considers other components such as performance, contributions, internal equity, and experience of each named executive officer in determining target and actual compensation amounts.

Compensation Elements

The primary components of our executive compensation program include:


Element			Objective
Base Salary			Provides a regular income at competitive market level and reflects each executive's skills, experience, and responsibilities
Annual Cash Incentive			Motivates our executives to achieve our annual operational and financial goals
Long-Term Equity Incentives			Reward sustained performance and align executives' interests with our stockholders
Benefits			Provide for the health and welfare of our executives, including retirement benefits to promote long-term commitment of our executives to the Company

Fiscal Year 2025 Compensation Changes

Effective for fiscal year 2025, the Compensation, Culture and People Committee, with guidance from our outside compensation consultant, who at the time was Korn Ferry, peer benchmarking data, and the CEO (in the case of named executive officers who are direct reports to the CEO), approved compensation changes for certain of our named executive officers to further increase the competitiveness of executive pay with continued focus on short-term and long-term Company performance and stockholder interests.

The Compensation, Culture and People Committee approved the following compensation increases for Mr. Calderone, Ms. Anderson, Mr. Crowe, and Ms. Laben: (i) Mr. Calderone received an increase of $100,000 to base salary, $100,000 to the target annual incentive amount and $300,000 to the target annual equity grant amount, (ii) Ms. Anderson received an increase of $125,000 to the target annual incentive amount and $250,000 to the target annual equity grant amount, (iii) Mr. Crowe received an increase of $125,000 to the target annual incentive amount and $225,000 to the target annual equity grant amount, and (iv) Ms. Laben received an increase of $100,000 to the target annual incentive amount. Additionally, in May 2024, in connection with the approval of the foregoing compensation changes and the annual equity grants for our named executed officers, the Committee approved one-time retention equity grants to encourage long-term retention and further align compensation with long-term Company performance for each of Messrs. Calderone and Crowe and Mses. Anderson and Laben in the amount of $3,000,000, $3,000,000, $3,000,000 and $1,000,000, respectively. Messrs. Calderone and Crowe and Ms. Anderson’s grants are comprised of 50% time-based restricted stock units and 50% performance-based restricted stock units, and Ms. Laben’s grant is comprised of 100% time-based restricted stock units. The named executive officers’ fiscal 2025 target annual cash incentive amounts are set forth below under the heading “Compensation Discussion and Analysis—Compensation Elements—Annual Cash Incentive”, the fiscal 2025 target annual equity grant amounts are set forth below under the heading “Compensation Discussion and Analysis—Compensation Elements—Long-Term Equity Incentives—Fiscal Year 2025 Annual Grants”, and the one-time retention grants are set forth below under the heading "Compensation Discussion and Analysis—Compensation Elements—Fiscal Year 2025 Retention Grants".

At-Risk Compensation

We believe that a significant portion of our named executive officers' compensation should be tied to the Company's success and the long-term returns of our stockholders. Consistent with this approach and as shown in the charts below for target compensation as of fiscal year-end 2025, more than half of the target compensation for each of our CEO and other named executive officers is delivered in the form of variable "at risk" compensation opportunities that are tied to the achievement of pre-set financial and operational goals.

Base Salary

Base salary represents a relatively small portion of the total target executive compensation opportunities and provides the fixed component necessary to attract and retain executive talent. The salary paid to each of our named executive officers in fiscal year 2025, as approved by the Compensation, Culture and People Committee, is set forth in the table below.


Name			FY25 Base Salary
Horacio D. Rozanski			$1,500,000
Matthew A. Calderone			$750,000
Kristine Martin Anderson			$900,000
Richard C. Crowe			$650,000
Nancy J. Laben			$650,000

Annual Cash Incentive

The annual cash incentive portion of our executives' compensation is provided through our annual bonus program. The target annual incentive amount for our named executive officers is determined each year by the Compensation, Culture and People Committee based on the market analysis and recommendation of our outside compensation consultant, as well as of the CEO (in the case of named executive officers who are direct reports to the CEO).

The target annual cash incentive value for each named executive officer is established as a fixed dollar value, as approved by the Compensation, Culture and People Committee generally near the beginning of each fiscal year. The actual annual incentive payout for each named executive officer is determined after the fiscal year ends, as described below, and calculated as a percentage of over- or under-performance relative to the applicable performance metric(s) as approved by the Compensation, Culture and People Committee and applied to the target annual incentive value. The performance metric(s) and the performance range are generally determined near the beginning of each fiscal year as approved by the Compensation, Culture and People Committee. Executives who retire, or terminate employment under our transition policy, before the end of the fiscal year are generally eligible to receive a prorated incentive payment.

Fiscal Year 2025 Annual Cash Incentive

For fiscal year 2025, the annual cash incentive was based on the Company's performance against two metrics — Adjusted EBITDA and an operational goal, as described below. The fiscal year 2025 target bonus pool, as approved by the Compensation, Culture and People Committee was $27.1M. Based on actual results against the target goals, as described below, the final approved bonus pool was $24.0 million.


Fiscal Year 2025 Performance Metrics		Weighting	Performance Metric Description
Financial Goal	Adjusted Earnings before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA)1	95%	One-year adjusted EBITDA measured against performance targets set at the start of the performance period
Operational Goal	Employee Experience Survey	5%	One-year results of a pre-determined subset of the companywide Employee Experience Survey for all employees against performance targets set at the start of the performance period

(1) See Appendix A to this proxy statement for information as to how these non-GAAP financial measures are calculated from our audited financial statements.

The Adjusted EBITDA portion of the annual incentive is determined based on the Company's performance relative to a target Adjusted EBITDA range. This incentive is subject to upward or downward adjustments based on how the performance compares to the specified range. Payment of the annual incentive approximating target levels would generally occur when actual Adjusted EBITDA is within the established Adjusted EBITDA range. A portion of any variance between the established range and actual Adjusted EBITDA is reflected as an adjustment to the pool of funds available for the annual incentive payment, or the bonus pool. The amount of the adjustment is determined by the Compensation, Culture and People Committee in its sole discretion. A positive variance between the range and actual Adjusted EBITDA would generally result in an increase in the bonus pool and a negative variance would generally result in a decrease in the bonus pool. The Compensation, Culture and People Committee also has discretion to reduce payouts when appropriate.

Adjusted EBITDA represents net income before income taxes, net interest and other expense and depreciation and amortization, and before certain other items, including transaction costs, fees, losses, and expenses, including fees associated with debt prepayments. We base the majority of the annual incentive portion of our executives' compensation on Adjusted EBITDA because we believe it is a direct reflection of the cash flow and operating profitability of our business and represents the element of our performance that executives can most directly impact through their management of the business. For fiscal year 2025, the Adjusted EBITDA goal was weighted as 95% of the overall annual incentive opportunity.


	FY25 Target Range	FY25 Actual 2
Adjusted EBITDA1	$1,246 million - $1,281 million	$1,315 million

(1) See Appendix A to this proxy statement for information as to how these non-GAAP financial measures are calculated

from our audited financial statements.

(2) Adjusted EBITDA results were $1,315 million, but for purposes of the fiscal year 2025 bonus payout, Adjusted EBITDA

was reduced to $1,285 million when adjusted for a one-time release of $30 million regulatory reserves.

For fiscal year 2025, the Compensation, Culture and People Committee, with guidance from management and our outside compensation consultant, who at the time was Korn Ferry, approved an operational goal for the annual cash incentive with a 5% weighting associated with our companywide Employee Experience Survey results for all employees. The Compensation, Culture and People Committee determined to include this goal in our annual incentive plan for fiscal year 2025 to support the organization's overall strategy, purpose and values on a short-term basis. The performance associated with companywide Employee Experience Survey results could range from zero percent for performance that falls below the minimum performance threshold and up to 150% for performance at the maximum level, in each case, as set and approved by the Compensation, Culture and People Committee near the beginning of each fiscal year.

Below Threshold Favorability

Threshold
Favorability

Target Favorability

Maximum
Favorability

Actual

Payout Factor

0% Payout

50% Payout

100% Payout

150% Payout

Employee Experience Survey for all employees

< 80.0%

80.0%

84.5% - 85.5%

88.0% +

85.7%

104.0%

Our Compensation, Culture and People Committee reviews and approves the Adjusted EBITDA and Employee Experience Survey and any adjustments to the plan bonus pool based on year-end results. The final bonus pool, as approved by our Compensation, Culture and People Committee, is distributed to our executives as a consistent percentage of the target value.

For fiscal year 2025, the Company's performance exceeded the top-end of the fiscal year 2025 target Adjusted EBITDA range; however, Company performance on other internal financial metrics came in lower than plan. In addition, the results of the Company’s Employee Experience Survey score goal were achieved above target. Based on these results, the Compensation, Culture and People Committee, in their discretion, approved the executive bonus payout equal to approximately 86%. The short-term incentive target opportunities and cash payments received by each of our named executive officers for fiscal year 2025 are presented in the table below.


Name	FY25 Annual Cash Incentive Target	Annual Cash Incentive Payout	Annual Cash Incentive Paid
Horacio D. Rozanski	$2,000,000	86%	$1,720,000
Matthew A. Calderone	$750,000	86%	$645,000
Kristine Martin Anderson	$775,000	86%	$666,500
Richard C. Crowe	$650,000	86%	$559,000
Nancy J. Laben	$650,000	86%	$559,000

Long-Term Equity Incentives

It is our philosophy that executives should hold meaningful amounts of long-term equity compensation to align the personal financial interests of our executives with the interests of long-term stockholders and to encourage a long-term perspective with regard to Company performance and growth. The equity compensation for our executives is delivered in the form of annual grants and new hire/advancement and retention grants.

Fiscal Year 2025 Annual Grants

Our named executive officers receive long-term equity incentive grants as part of their annual compensation that have two components: time-based restricted stock units (RSUs) and performance-based RSUs.

•Time-Based RSUs: Settle into shares of Class A common stock in three equal installments over three years, subject solely to continued employment through each applicable vesting date.

•Performance-Based RSUs: Settle into shares of Class A common stock at the end of a three-year performance period. For fiscal year 2025, the performance-based RSU goals are based on the Company's cumulative performance against two internal financial metrics — Adjusted EBITDA and Revenue and a total shareholder return (TSR) multiplier.


Fiscal Year 2025 Performance Metrics		Weighting	Performance Metric Description
Financial Metrics	Adjusted Earnings before Interest, Taxes, Depreciation, and Amortization (Adjusted EBITDA)1	75%	Three-year cumulative adjusted EBITDA measured against performance targets set at the start of the performance period
	Revenue1	25%	Three-year cumulative revenue measured against performance targets set at the start of the performance period
TSR Multiplier	Total Shareholder Return	20% Multiplier	Three-year comparison of the Company's total shareholder return relative to the S&P Software and Services Select Industry Index

(1) See Appendix A to this proxy statement for information as to how these non-GAAP financial measures are calculated from our audited financial statements.

The Compensation, Culture and People Committee approved Adjusted EBITDA and Revenue as the financial metrics for

performance-based RSUs granted in fiscal year 2025 to create a direct relationship between named executive officer compensation and performance against the Company’s multi-year Investment Thesis, as presented to stockholders, which is focused on driving organic revenue and Adjusted EBITDA. The Compensation, Culture and People Committee approved the use of Adjusted EBITDA as a metric in both of the annual and long-term incentive plans in fiscal year 2025 because it is viewed as a direct reflection of the cash flow and operating profitability of our business and represents the element of performance that executives can most directly impact through their management of the business. The Company views Adjusted EBITDA as a critical metric in evaluating operating performance as a measure of the Company's ability to drive profitable growth through a combination of revenue performance and cost management to optimize earnings generation for stockholders. Further, the Compensation, Culture and People Committee approved the application of a TSR multiplier for performance-based RSUs granted in fiscal year 2025 because it viewed such multiplier as creating additional risk and reward for executive compensation based on significant over- or under-performance against a broad group of industry peers. The Compensation, Culture and People Committee, with guidance from management and our outside compensation consultant, who at the time was Korn Ferry, did not include an operational metric in the performance-based RSUs granted in fiscal year 2025, and instead included an operational goal in our annual cash incentive plan for fiscal year 2025 to support the organization’s overall strategy, purpose and values on a short-term basis, as discussed above.

At the start of the three-year performance cycle, the Compensation, Culture and People Committee sets the threshold, target and maximum performance levels, and corresponding payouts. When establishing these performance levels, the Compensation, Culture and People Committee considers, among other things, projected Company performance and long-term strategic growth objectives, business outlook, and market growth forecasts. Since the goals are established for future performance over a three-year period, outcomes are by definition uncertain. Due to the proprietary and competitive nature of the Company's business strategy and internal budgets that inform the three-year performance program targets, the Compensation, Culture and People Committee discloses the long-term performance levels for each of the performance goals following the completion of the performance period.

The number of performance-based RSUs that vest at the end of the three-year performance cycle based on the financial performance goals may range from zero percent for performance that falls below the minimum performance threshold and up to 200% for maximum performance. The number of restricted stock units earned based on the financial performance goals may be further increased or decreased by the application of the TSR multiplier relative to the companies within the S&P

Software and Services Select Industry Index. The TSR multiplier is dependent upon the Company’s TSR positioning against the companies within the Index during the performance period (multiplier is 120% if the Company’s TSR is at or above the 75th percentile, 80% if TSR is at or below the 25th percentile, and no modifications between the 25th and 75th percentiles). The maximum number of performance-based RSUs granted in fiscal year 2025 that may be earned by a named executive officer after application of the TSR multiplier is 240% of target value.

For fiscal year 2025, the target annual equity mix for our CEO was 61.2% aligned to performance-based RSUs and 38.8% aligned to time-based RSUs. The average target annualized equity mix for all other named executive officers was approximately 60% aligned to performance-based RSUs and approximately 40% aligned to time-based RSUs. The performance-based RSUs allow for additional rewards based on over-achievement against our long-term performance goals, while also penalizing for under-performance. The time-based RSUs encourage retention and provide for incremental recognition of equity compensation over the vest cycle.

The target value of the annual grants to our named executive officers of performance-based and time-based RSUs in fiscal year 2025 are presented in the table below.


Name	FY25 Annual Target Performance-Based RSU Grant 1	FY25 Annual Target Time-Based RSU Grant 1
Horacio D. Rozanski	$6,651,183	$3,880,152
Matthew A. Calderone	$1,108,558	$680,135
Kristine Martin Anderson	$1,304,274	$800,042
Richard C. Crowe	$847,770	$520,005
Nancy J. Laben	$1,043,320	$640,064

(1) Grant date fair value of equity issued under the fiscal year 2025 executive annual compensation structure in accordance with FASB ASC Topic 718.

Fiscal Year 2025 Retention Grants

In the previous year, on May 21, 2024, in connection with the approval of the fiscal year 2025 compensation changes and annual equity grants for our named executed officers, as discussed above, the Committee approved one-time equity grants for each of Messrs. Calderone and Crowe and Mses. Anderson and Laben, in the amounts of $3,000,000, $3,000,000, $3,000,000 and $1,000,000, respectively. Messrs. Calderone and Crowe's and Ms. Anderson’s grants are comprised of 50% time-based restricted stock units and 50% performance-based restricted stock units, and Ms. Laben’s grant is comprised of 100% time-based restricted stock units. The performance-based restricted stock units have the same performance goals as the annual grants awarded in fiscal year 2025. These grants are designed to strengthen the focus on driving long-term performance and ensuring the retention of our senior leadership, thereby driving sustained growth and value creation for the Company in support of our multi-year VoLT strategy. The target value of these one-time equity grants to our named executive officers are presented in the table below.


Name	FY25 Target One-Time Retention Performance-Based RSU Grant 1	FY25 Target One-Time Retention Time-Based RSU Grant 1
Matthew A. Calderone	$1,630,301	$1,500,137
Kristine Martin Anderson	$1,630,301	$1,500,137
Richard C. Crowe	$1,630,301	$1,500,137
Nancy J. Laben	$0	$1,000,091

(1) Grant date fair value of equity issued under the fiscal year 2025 executive annual compensation structure in accordance with FASB ASC Topic 718.

Fiscal Year 2023-2025 Performance-Based RSU Awards

In May 2025, the Compensation, Culture and People Committee reviewed and certified the performance results of the performance-based RSUs granted in May 2022, applicable for the fiscal years 2023-2025 performance period, against the targets set at the beginning of the three-year period. The goals included two financial metrics, Adjusted EBITDA and Revenue, weighted 70% and 20%, respectively, and two non-financial strategic goals, each with a 5% weighting. The Compensation, Culture and People Committee determined to eliminate the opportunity to vest the performance-based RSUs associated with one of the non-financial strategic goals for the fiscal year 2023-2025 grant, resulting in 95% target for the combined three remaining goals.

Based on its assessment of the Adjusted EBITDA, Revenue, and Platform Revenue growth goals, the Compensation, Culture and People Committee approved a final payout percentage for the May 2022 performance-based RSU awards (fiscal years 2023-2025 performance period) of 15% above target, with actual financial results and threshold, target, above target, and maximum goals presented in the table below.


Performance Measures	Weighting	Below Threshold	Threshold	Above Threshold	Target	Above Target			Maximum	Actual 1	% of Target Achieved	Payout Factor
		0% Payout	50% Payout	90% Payout	100% Payout	110% Payout	150% Payout	175% Payout	200% Payout
Cumulative Three-Year Adjusted EBITDA	70%	$3,236	$3,237 - $3,275	$3,276 - $3,323	$3,324 - $3,535	$3,536 - $3,604	$3,605 - $3,678	$3,679 - $3,819	$3,820 +	$3,505	100%	70%
Cumulative Three-Year Revenue	20%	$27,353	$27,354 - $27,660	$27,661 - $28,199	$28,200 - $28,746	$28,747 - $29,299	$29,300 - $29,889	$29,890 - $30,456	$30,457 +	$31,669	200%	40%
Cumulative Revenue Growth of Platform Businesses	5%	< 10.0%	10.0% - 14.9%		15.0% - 24.9%	–			25.0% +	15.6%	100%	5%
Total	95%											115%

(1) See Appendix A to this proxy statement for a reconciliation between each non-GAAP financial measure and the most directly comparable financial measure calculated and presented in accordance with GAAP.

In addition, the Compensation, Culture and People Committee determined in fiscal year 2025 to eliminate the opportunity to vest the performance-based RSUs associated with one of the non-financial strategic goals for the fiscal year 2024-2026 grant, resulting in 95% target for the combined three remaining goals.

Benefits and Perquisites

Our employees are eligible to participate in a full complement of benefit plans. Our named executive officers also participate in enhanced medical and dental plans, life insurance, accidental death and dismemberment, and personal liability coverage at the Company's expense. During fiscal year 2025, our named executive officers were eligible to receive perquisites, including up to $15,000 per year for financial counseling, up to $7,500 every three years to update an estate plan, and up to $3,000 for preparation of estate plans following relocation to a new tax jurisdiction. In addition, to protect our executives from various risks, we maintain an executive protection program that provides our executives with a security assessment for their primary residence and security service for international or domestic travel. We believe that our executive benefit and perquisite programs are reasonable and necessary to provide for the well-being of our executives. For more detail on the perquisites that our named executive officers receive, see footnote 7 to the Summary Compensation Table.

Retirement Benefits

We provide retirement benefits to our executives, including our named executive officers, to help them build financial security for retirement, while allowing them to direct the investment of their retirement savings as they choose. For a description of these benefits, see "Potential Payments upon Termination or a Change in Control — Retirement Benefits." below.

Employees’ Capital Accumulation Plan

All eligible employees, which includes our named executive officers, may participate in the tax-qualified Employees' Capital Accumulation Plan, or ECAP. Under this plan, eligible employees, including our named executive officers, receive an annual matching contribution based on their voluntary contributions up to 6% of their eligible annual income, as determined by the Internal Revenue Code of 1986, as amended (the "Code"). Each executive is also eligible to receive a payment that is equivalent to the annual tax-deferred contribution he or she is permitted to make to the ECAP under the Code. Executives may elect to have these funds deposited into a pre-tax or Roth 401(k), or the executive may simply receive the funds as a cash payment and be taxed accordingly.

Non-Qualified Deferred Compensation Plan

As part of our executive compensation program, we offer a non-qualified deferred compensation plan for our executives to encourage employees to save for their retirement. Eligible employees, which include all named executive officers, may elect to contribute up to 100% of their annual cash bonus to this plan. Mr. Crowe was the only named executive officer who participated in the non-qualified deferred compensation plan in fiscal year 2025. For a description of these benefits, see "Non-qualified Deferred Compensation Table" below.

Additional Retirement Benefits

We provide additional retirement benefits to our executives, including our named executive officers, in order to provide them with additional security in retirement and promote a long-term career with our Company. Our named executive officers participate in the Officers' Retirement Plan, under which the executive may retire with full benefits after a minimum of either (a) age 60 with five years of service as an executive, or (b) age 50 with 10 years of service as an executive. Under the Officers' Retirement Plan, an eligible executive who retires and does not receive severance benefits is entitled to receive a single lump-sum retirement payment equal to $20,000 for each year of service as an executive, pro-rated as appropriate. Our retirees are also eligible to receive comprehensive coverage for medical, pharmacy, and dental healthcare. The premiums for this healthcare coverage are paid by the Company.

Executive Ownership Requirements

Equity ownership requirements are in place for our executives, including our named executive officers, to further align their interests to those of our stockholders. Our ownership requirements extend beyond market expectations. Our named executive officers have regularly exceeded our equity ownership guidelines and demonstrate a commitment to the Company's long-term value by owning equity well above their requirements. Until an executive has satisfied the ownership requirements set forth below, the executive cannot sell any equity granted as executive equity compensation by the Company. Each executive’s required equity ownership amount is determined as a multiple of his or her base salary. The applicable multiples for our named executive officers are set forth in the table below, as well as a comparison of their approximate actual equity ownership requirement as of the end of the fiscal year:


Named Executive Officers	Ownership Requirement	NEO Actual Ownership 1
Chief Executive Officer	7x base salary	57x base salary
Other named executive officers	4x base salary	14x base salary

(1) Ownership for the "other named executive officers" is an average of their equity holdings compared to their respective base salary amounts as of fiscal year-end 2025. Performance-based RSUs that vested on March 31, 2025 are included at target for purposes of this calculation.

In calculating an executive's ownership, Class A Common Stock, vested in-the-money stock options, restricted stock, restricted stock units, and outstanding performance stock units at target, issued under the Equity Incentive Plan are considered as owned by the executive. Each of our named executive officers has satisfied his or her individual stock ownership requirement.

Risk Assessment

During fiscal year 2025, we conducted an internal risk assessment of our compensation programs with participation from our outside compensation consultant, who at the time was Korn Ferry. Based on our approach of compensating our executives to foster the financial success of the Company as a whole and other elements of our compensation system, our Compensation, Culture and People Committee, with the information from our internal review, concluded that our executive compensation program does not encourage undue risk taking and the risks arising from our compensation policies and practices for our employees are not reasonably likely to have a material adverse effect on the Company.

Advisory Vote to Approve Executive Compensation

At the 2024 Annual Meeting of Stockholders, approximately 97% of the votes cast were in favor of our executive compensation structure. The Board and Compensation, Culture and People Committee viewed this strong support as an indicator of general approval of our approach to executive compensation. In 2023, the Company’s stockholders approved the recommendation of holding the say-on-pay vote annually. The next advisory vote for the frequency of holding the say-on-pay vote is scheduled for the Annual Meeting of Stockholders in 2029. We continue to engage with our stockholders and welcome feedback regarding our executive compensation programs.

Government Limitations on Reimbursement of Compensation Costs

We are subject to applicable federal statutes and the Federal Acquisition Regulation (FAR), which govern the reimbursement of costs by our government customers. Pursuant to the FAR our contracts limit the allowability of reimbursement for compensation to certain, or in some cases all, employees, including our named executive officers, to a benchmark compensation cap established each year by the Office of Management and Budget (OMB). When comparing compensation to the benchmark cap, all wages, salary, bonuses, deferred compensation, and employer contributions to defined contribution pension plans, if any, for the year, as recorded in our books and records, must be included. Any amounts over the cap are considered unallowable and are therefore not recoverable under our government contracts. The compensation cap established by the OMB, which is applicable to a portion of our contracts for the 2025 calendar year, is $671,000. Other contracts have higher caps and/or limit the allowable compensation of fewer employees.

Compensation Recovery Provisions (Clawbacks)

The Company maintains a mandatory clawback policy in accordance with Section 10D of the Exchange Act and Section 303A.14 of the NYSE Listed Company Manual (the "Rule 10D-1 Clawback Policy"). The Rule 10D-1 Clawback Policy requires the Company to recover from its executive officers certain incentive-based compensation in the event that the Company is required to prepare an accounting restatement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, without regard to any misconduct on the part of the executive and subject to certain limited exceptions. The Rule 10D-1 Clawback Policy applies to incentive-based compensation (whether cash- or equity-based) received by current and former executive officers of the Company during the three fiscal years preceding an accounting restatement and after the effective date of the NYSE listing standards, which was October 2, 2023. The Compensation, Culture and People Committee administers this policy.

We also have provisions in our incentive plans that provide us with the ability to impose the forfeiture of bonuses and all equity compensation and the recovery of certain bonus amounts and gains from equity compensation awarded under those plans. Such forfeitures and recoveries may occur:

•in the event of an accounting restatement due to material noncompliance with any financial reporting requirements under the securities laws with respect to individuals who knowingly or grossly negligently engaged in misconduct or knowingly or grossly negligently failed to prevent the misconduct,

•with respect to individuals subject to automatic forfeiture under Section 304 of the Sarbanes-Oxley Act of 2002, and,

•to the extent that, based on erroneous data, any award or payment under the Annual Incentive Plan is in excess of what would have been paid under the accounting restatement during the three-year period preceding the date on which a financial restatement is required, current or former executives, or as otherwise required under applicable laws or regulations.

In addition, if an individual engages in certain other misconduct, including if (i) the participant’s performance is deemed to contribute substantially to significant financial losses, (ii) the participant’s performance is deemed to contribute substantially to a significant downward restatement of any published results of our company or a subsidiary, (iii) the participant’s conduct results in or contributes substantially to significant reputational harm to our company, (iv) the participant materially breaches applicable legal and/or regulatory requirements, or, with respect to any conduct by other employee(s) that materially breaches or contributes substantially to a material breach of applicable legal and/or regulatory requirements, the participant had supervisory authority over the employee(s) or business area engaged in the conduct and knew of, or was willfully blind to, such conduct, (v) the participant’s conduct constitutes cause or (vi) the participant’s conduct results in or contributes substantially to a material breach of our applicable internal policies and procedures, the Company has the discretion to suspend vesting of all or a portion of any award and/or require the forfeiture or disgorgement to the Company of any equity award (including gains on the sale of the stock, if any) that vested, was paid, or settled in the 24 months prior to or any time after the individual engaged in such misconduct.

Our Equity Incentive Plan and Annual Incentive Plan also permit the Company to subject awards to forfeiture, disgorgement, and recoupment under any applicable clawback policies that may be adopted by the Board or our Compensation, Culture and People Committee, including our Rule 10D-1 Clawback Policy.

Certain Change in Control Provisions

Equity Awards

The 2023 Equity Incentive Plan of the Company (the “Equity Incentive Plan”) was approved by our stockholders in July 2023 and governs equity awards made to our named executive officers beginning in fiscal year 2025. The Equity Incentive Plan provides that, upon a change in control, unless otherwise determined by the Compensation, Culture and People Committee or as otherwise provided in an award agreement, any unvested or unexercisable time-based and performance-based awards granted under the Equity Incentive Plan will not become fully vested upon the occurrence of a change in control, and will instead be honored, assumed or substituted following the change in control, so long as such substitute awards (i) provide a participant with rights and entitlements (including economic value) that are substantially equivalent to or better than the rights and terms applicable to the awards held by such participant immediately prior to the change in control, and (ii) provide for accelerated vesting upon an involuntary termination of a participant’s employment without cause or for good reason within two years following the occurrence of the change in control. If the awards are not honored, assumed or substituted upon a change in control, then any time-based awards granted under the Equity Incentive Plan, including time-based options and time-based restricted stock units, will fully vest, and a portion of any outstanding performance-based awards granted under the Equity Incentive Plan, including performance-based restricted stock units, will vest based on performance achieved as of the consummation of the transaction constituting a change in control.

With respect to outstanding equity awards granted to our named executive officers under the Third Amended and Restated Equity Incentive Plan in fiscal years 2024 and 2023, pursuant to the terms of the applicable award agreements as approved by our Compensation, Culture and People Committee, in the event of a change in control:

•all time-based options and time-based restricted stock units shall remain outstanding and vest on the applicable vesting date, subject to the continued employment or service of the participant with the Company or any subsidiary thereof through such vesting date. However, if the participant’s employment or service is terminated by the Company without “cause” or for “good reason” (in each case, as defined in the applicable award agreement) within two years following the effective date of the change in control transaction (each, a "Qualifying Termination"), such outstanding options and restricted stock units will vest as of the date of such termination; and

•unvested performance-based restricted stock units will remain outstanding at target levels and will vest on the original vesting date, subject to the continued employment or service of the participant by the Company or any subsidiary thereof through such vesting date, but without regard to achievement of any performance goals; however, if the participant’s employment or service is terminated in a Qualifying Termination within two years following the effective date of the change in control, such outstanding restricted stock units will vest as of the date of such termination.

“Change in control” is generally defined in our Equity Incentive Plan to mean the acquisition by any person of 50% or more of the combined voting power of our Company's then outstanding voting securities, the merger of our Company if our stockholders immediately prior to the merger do not own more than 50% of the combined voting power of the merged entity, the liquidation or dissolution of our Company (other than in a bankruptcy proceeding or for the purposes of effecting a corporate restructuring or reorganization), or the sale of all or substantially all the assets of our Company to non-affiliates.

Retiree Medical Plan

If, during the five-year period after a change in control, our executives' retiree medical plan is terminated or modified in a manner that is materially adverse to our executives, each of our executives, including our named executive officers, will be guaranteed their existing benefits under the plan through the fifth anniversary of the change in control and receive at the end of the five-year period a cash payment equal to the excess of the actuarial cost of the executive's benefits under the plan that would be accrued on the Company's financial statements on the fifth anniversary of the change in control in the absence of the termination or modification over the amount that is accrued on our financial statements on the fifth anniversary of the change in control giving effect to the termination or modification (but excluding the accrual on the payment itself).

Policies on Timing of Equity Grants

It is our policy not to time the granting of equity awards, including stock option awards, in relation to the release of material non-public information. Accordingly, regularly scheduled awards are permitted to be granted at times when there is material non-public information. Annual equity awards to all officers, including the named executive officers, are typically granted by the Compensation, Culture and People Committee at its prescheduled meeting in May of each fiscal year. We generally grant equity awards to newly hired and promoted executive officers at the subsequently scheduled Compensation, Culture and People Committee or Board meeting following the respective effective date of the hire or promotion. We do not time the disclosure of material non-public information for the purpose of affecting the value of executive compensation.

Effect of Accounting and Tax Treatment on Compensation Decisions

The Compensation, Culture and People Committee has from time to time considered the potential impact of Section 162(m) of the Code, or Section 162(m), on elements of our compensation program. Section 162(m) imposes a limit on the amount of compensation that we may deduct in any one year with respect to certain “covered employees.” The 2017 Tax Cuts and Jobs Act made certain changes to Section 162(m), including repealing the performance-based compensation exception and expanding the scope of persons covered by the limitations on deductibility under Section 162(m). Accordingly, compensation paid after March 31, 2018 to our covered employees in excess of $1 million will not be deductible unless it qualifies for transition relief applicable to certain arrangements in place as of November 2, 2017 that are not modified in any material respect after that date.

Our Compensation, Culture and People Committee considers it important to retain the flexibility to design compensation programs that are in the best long-term interests of our Company and our stockholders and does not have a policy requiring compensation to be fully deductible under Section 162(m). As a result of the elimination of the exemption for qualified performance-based compensation, our Compensation, Culture and People Committee pays and expects to continue paying compensation at levels that are not deductible under Section 162(m).

Other provisions of the Code can also affect compensation decisions. Section 409A of the Code, or Section 409A, which governs the form and timing of payment of deferred compensation, imposes sanctions, including a 20% penalty and an interest penalty, on a recipient of deferred compensation that does not comply with Section 409A. Our Compensation, Culture and People Committee takes into account the potential implications of Section 409A in determining the form and timing of compensation awarded to our executives and strives to structure its nonqualified deferred compensation plans to meet these requirements.

Section 280G of the Code, or Section 280G, disallows a company's tax deduction for payments received by certain individuals in connection with a change in control to the extent that the payments exceed an amount approximately three times their average annual compensation and Section 4999 of the Code imposes a 20% excise tax on those payments. As described above, awards under our Equity Incentive Plan contain provisions that, in certain circumstances, accelerate vesting of all or a portion of the awards in connection with a change in control and Qualifying Termination within two years following the change in control. To the extent that payments upon a change in control are classified as excess parachute payments, our Company's tax deduction would be disallowed under Section 280G.

Compensation Tables and Disclosures


SUMMARY COMPENSATION TABLE
Name and Principal Position	Fiscal Year 1	Salary	Bonus	Stock Awards 2	Option Awards	Non-Equity Incentive Plan Compensation 3	Change in Pension Value and Nonqualified Deferred Compensation Earnings 4	All Other Compensation 6 7	Total
		($)	($)	($)	($)	($)	($)	($)	($)
Horacio D. Rozanski President & Chief Executive Officer	2025	1,500,000	—	10,531,335	—	1,720,000	20,000	227,804	13,999,139
	2024	1,500,000	—	10,406,765	—	3,200,000	255,000	231,993	15,593,758
	2023	1,500,000	—	8,500,083	—	1,875,600	10,000	298,102	12,183,785
Matthew A. Calderone Executive Vice President, Chief Financial Officer	2025	750,000	—	4,919,130	—	645,000	20,000	164,613	6,498,743
	2024	650,000	—	1,455,856	—	1,040,000	130,000	154,948	3,430,804
	2023	650,000	—	770,498	250,007	593,940	10,367	145,162	2,419,974
Kristine Martin Anderson Executive Vice President, Chief Operating Officer	2025	900,000	—	5,234,753	—	666,500	20,000	191,393	7,012,646
	2024	900,000	—	1,819,869	—	1,040,000	150,000	162,650	4,072,519
	2023	858,333	—	3,658,415	—	750,240	10,000	183,349	5,460,337
Richard C. Crowe 5 Executive Vice President, President of Civilian Services Sector	2025	650,000	—	4,498,212	—	559,000	20,000	156,892	5,884,104


Nancy J. Laben Executive Vice President, Chief Legal Officer	2025	650,000	—	2,683,475	—	559,000	20,000	251,879	4,164,354
	2024	650,000	—	1,663,839	—	880,000	115,000	292,929	3,601,768
	2023	650,000	—	1,362,680	—	640,830	10,000	215,221	2,878,731

(1)Compensation is provided only for fiscal years for which each individual qualified as a named executive officer. The fiscal year runs from April 1 through March 31 of the subsequent calendar year.

(2)This column reflects the aggregate grant date fair value of the time- and performance-based restricted stock units granted to our named executive officers in fiscal year 2025. The grant date fair value of the time-based restricted stock units is measured in accordance with FASB ASC 718 and based on the closing price of the Company’s common stock on the date of grant. The grant date fair value of the performance-based restricted stock units is calculated using a Monte-Carlo model for each award on the date of grant, as determined under FASB ASC 718 based on the probable outcome of the performance condition as of the grant date. This column reflects the grant assumptions set forth in Note 18 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, which are incorporated by reference herein, modified to exclude any forfeiture assumptions related to service-based vesting conditions. The amounts in this column do not reflect the value, if any, that ultimately may be realized by the executive. Assuming the maximum level of performance is achieved, the value at the grant date of the fiscal year 2025 performance-based restricted stock units reflected in this column would be as follows: Mr. Rozanski, $14,688,266; Mr. Calderone, $6,048,387, Ms. Anderson, $6,480,480, Mr. Crowe, $5,472,466, and Ms. Laben, $2,303,988.

(3)This column reflects the fiscal year 2025 annual cash incentive bonus program, which provides awards based on the achievement of corporate performance objectives. The amounts reported in this column relate to the year in which such bonuses were earned by each of our named executive officers. See “Compensation Discussion and Analysis—Compensation Elements—Annual Cash Incentive” for additional detail regarding the annual performance bonus program.

(4)This column reflects the change in the actuarial present value of the cash retirement benefit accrued under the Officers' Retirement Plan for each of our named executive officers from fiscal year-end 2023 to fiscal year-end 2025.

(5)Mr. Crowe was not a named executive officer in fiscal years 2023 and 2024. Accordingly, no compensation information is provided for Mr. Crowe for such fiscal years.

(6)The amounts shown for Ms. Laben in the "All Other Compensation" and "Total" columns for fiscal year 2024 have been adjusted to reflect the correct total amount of All Other Compensation for such fiscal year. In our prior year's proxy statement, the amount of All Other Compensation for fiscal year 2024 was misstated in the Summary Compensation Table but was accurately reported in note 7 to the Summary Compensation Table.

(7)The table below describes the elements included in All Other Compensation for fiscal year 2025.


OTHER COMPENSATION TABLE
Name	Financial Counseling a	Qualified Company Contributions to 401(k)	Company Non- Qualified Retirement Contributions to Employees b	Executive Medical and Retiree Plan Contributions	Life Insurance	Other c	Total
	($)	($)	($)	($)	($)	($)	($)
Horacio D. Rozanski	15,000	20,700	30,500	65,276	5,862	90,466	227,804
Matthew A. Calderone	15,000	20,700	30,500	65,276	3,846	29,291	164,613
Kristine Martin Anderson	8,079	20,700	30,500	65,276	5,862	60,976	191,393
Richard C. Crowe	6,599	20,700	30,500	65,276	6,426	27,391	156,892
Nancy J. Laben	12,800	20,700	30,500	65,276	12,444	110,159	251,879

(a)This column reflects the standard financial counseling benefit received by each named executive officer pursuant to the Company's Officer Perquisites Policy, which is limited to $15,000 on a calendar year basis.

(b)This column represents retirement plan contributions paid by the Company to the named executive officers as described above under “Compensation Discussion and Analysis—Compensation Elements—Retirement Benefits.”

(c)This column includes dental, supplemental medical, accident insurance, personal excess liability coverage, and vehicle parking for each named executive officer, as well as an anniversary gift for Mr. Crowe. This column also includes security services for Mr. Rozanski ($61,176), Ms. Anderson ($35,285), and Ms. Laben ($84,469).


GRANTS OF PLAN-BASED AWARDS TABLE
			Estimated Possible Payouts Under Non-Equity Incentive Plan Awards 1			Estimated Future and Possible Payouts Under Equity Incentive Plan Awards 2			All Other Stock Awards; Number of Shares or Stock Units 3	All Other Option Awards; Number of Securities Underlying Options	Exercise or Base Price of Option Awards	Grant Date Fair Value of Stock and Option Awards 4 ($)
			Threshold	Target	Max	Threshold	Target	Max
Name	Grant Date	Approval Date	($)	($)	($)	(#)	(#)	(#)
Horacio D. Rozanski
Annual Incentive Plan		5/21/2024	—	2,000,000	—	—	—	—	—	—	—	—
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	20,084	40,169	96,405	—	—	—	6,651,183
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	25,467	—	—	3,880,152
Matthew A. Calderone
Annual Incentive Plan		5/21/2024	—	750,000	—	—	—	—	—	—	—	—
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	3,347	6,695	16,068	—	—	—	1,108,558
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	4,464	—	—	680,135
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	4,923	9,846	23,630	—	—	—	1,630,301
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	9,846	—	—	1,500,137
Kristine Martin Anderson
Annual Incentive Plan		5/21/2024	—	775,000	—	—	—	—	—	—	—	—
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	3,938	7,877	18,904	—	—	—	1,304,274
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	5,251	—	—	800,042
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	4,923	9,846	23,630	—	—	—	1,630,301
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	9,846	—	—	1,500,137
Richard C. Crowe
Annual Incentive Plan		5/21/2024	—	650,000	—	—	—	—	—	—	—	—
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	2,560	5,120	12,288	—	—	—	847,770
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	3,413	—	—	520,005
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	4,923	9,846	23,630	—	—	—	1,630,301
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	9,846	—	—	1,500,137
Nancy J. Laben
Annual Incentive Plan		5/21/2024	—	650,000	—	—	—	—	—	—	—	—
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	3,150	6,301	15,122	—	—	—	1,043,320
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	4,201	—	—	640,064
Equity Incentive Plan	5/23/2024	5/21/2024	—	—	—	—	—	—	6,564	—	—	1,000,091

(1)Reflects the target bonus for fiscal year 2025 under our Annual Incentive Plan, which provides awards based on the achievement of corporate performance objectives, payable in cash. The Annual Incentive Plan is described more fully under “Compensation Discussion and Analysis—Compensation Elements—Annual Cash Incentive.” Non-equity incentive plan awards have no minimum threshold or maximum payouts, although our plan does limit the annual amount of bonus an individual can earn to $5,000,000. The actual cash bonuses paid for fiscal year 2025 are reflected in the Summary Compensation Table.

(2)Reflects the target number of performance-based restricted stock units granted pursuant to the Equity Incentive Plan in May 2024. The performance-based restricted stock units are determined by the Company's performance against two financial metrics, Adjusted EBITDA (75% weighting) and Revenue (25% weighting), and a relative Total Shareholder Return multiplier based on cumulative performance over a three-year period. The threshold payout for the performance-based restricted stock units is reflected at 50% of target and does not include a modifier for TSR performance. The maximum payout is reflected at 240% of target, with inclusion of the maximum TSR modifier of 120% modifier to represent absolute maximum performance. See “Compensation Discussion and Analysis—Compensation Elements—Long-Term Equity Incentives" for details regarding these grants.

(3)Reflects the time-based restricted stock units granted pursuant to the Equity Incentive Plan in May 2024, which vest in equal annual installments over three years based on the continued employment of the named executive officer. See "Compensation Discussion and Analysis—Compensation Elements—Long-Term Equity Incentives" for details regarding these grants.

(4)The grant date fair value for time-based restricted stock units is measured in accordance with FASB ASC 718 and based on the closing price of the Company’s common stock on the date of grant. The grant date fair value for performance-based restricted stock units is calculated using a Monte-Carlo model for each award on the date of grant, as determined under FASB ASC 718 based on the probable outcome of the performance condition as of the grant date. The grant date fair value for the time- and performance-based restricted stock units reflects the grant assumptions set forth in Note 18 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, which are incorporated by reference herein.


OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE
		Option Awards					Stock Awards
Name	Grant Date	Number of Securities Underlying Unexercised Options Exercisable (#)	Number of Securities Underlying Unexercised Options Unexercisable (#)1	Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#)	Option Exercise Price ($)	Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#) 2	Market Value of Shares or Units of Stock That Have Not Vested ($) 3	Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#) 4	Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) 5
Horacio D. Rozanski	5/23/2024						—	—	96,405	10,082,035
	5/23/2024						16,978	1,775,559	—	—
	5/25/2023						—	—	159,386	16,668,588
	5/25/2023						14,396	1,505,534	—	—
Matthew A. Calderone	5/23/2024						—	—	16,068	1,680,391
	5/23/2024						2,976	311,230	—	—
	5/23/2024						—	—	23,630	2,471,225
	5/23/2024						6,564	686,463	—	—
	5/25/2023						—	—	21,876	2,287,792
	5/25/2023						2,079	217,422	—	—
	5/17/2022	9,024	6,016	—	83.38	5/17/2032	—	—	—	—
	5/23/2018	26,716	—	—	41.28	5/23/2028	—	—	—	—
Kristine Martin Anderson	5/23/2024						3,501	366,135	—	—
	5/23/2024						—	—	18,904	1,976,980
	5/23/2024						6,564	686,463	—	—
	5/23/2024						—	—	23,630	2,471,225
	5/25/2023						2,597	271,594	—	—
	5/25/2023						—	—	27,347	2,859,949
	5/19/2022						9,279	970,398	—	—
	5/22/2019	10,195	—	—	62.12	5/22/2029	—	—	—	—
	1/29/2019	12,947	—	—	47.99	1/29/2029	—	—	—	—
	5/23/2018	26,716	—	—	41.28	5/23/2028	—	—	—	—
Richard C. Crowe	5/23/2024						—	—	12,288	1,285,079
	5/23/2024						2,276	238,024	—	—
	5/23/2024						—	—	23,630	2,471,225
	5/23/2024						6,564	686,463	—	—
	5/25/2023						—	—	16,798	1,756,735
	5/25/2023						1,596	166,910	—	—
	5/27/2022	5,790	8,688	—	86.86	5/27/2032	—	—	—	—
	5/22/2019	20,391	—	—	62.12	5/22/2029	—	—	—	—
Nancy J. Laben	5/23/2024						2,801	292,929	—	—
	5/23/2024						—	—	15,122	1,581,459
	5/23/2024						4,376	457,642	—	—
	5/25/2023						—	—	25,002	2,614,709
	5/25/2023						2,375	248,378	—	—
	11/14/2018	23,193	—	—	51.22	11/14/2028	—	—	—	—

(1)The options reported in this column were granted pursuant to the Prior Equity Incentive Plan and will vest and become exercisable, subject to the continued employment of the named executive officer, on the dates set forth in the table below:


Name	Option Exercise Price	May 31, 2025	March 31, 2026	May 31, 2026	March 31, 2027	May 31, 2027	Total
Matthew A. Calderone	83.38	—	3,008	—	3,008	—	6,016
Richard C. Crowe	86.86	2,895	—	2,895	—	2,898	8,688

Upon a change in control, such options will remain outstanding and vest on the original vesting date, subject to the continued employment or service through such date; provided, that, if the participant’s employment or service is terminated by the Company without cause or for good reason within two years following the effective date of the change in control, the outstanding options will vest as of the date of termination.

(2) The time-based restricted stock units reported in this column will vest, subject to the continued employment of the named executive officer, on the dates set forth in the table below:


Name	June 1, 2025	March 31, 2026	March 31, 2027	Total
Horacio D. Rozanski	—	22,885	8,489	31,374
Matthew A. Calderone	—	6,849	4,770	11,619
Kristine Martin Anderson	9,279	7,629	5,033	21,941
Richard C. Crowe	—	6,016	4,420	10,436
Nancy J. Laben	—	5,963	3,589	9,552

Upon a change in control, such outstanding time-based restricted stock units will remain outstanding and vest on the original vesting date, subject to the continued employment or service through such date; provided, that, if the participant’s employment or service is terminated by the Company without cause or for good reason within two years following the effective date of the change in control, the outstanding time-based restricted stock units will vest as of the date of termination.

(3) The market value reported in this column has been determined based on the fair market value of our common stock on March 31, 2025 of $104.58.

(4) This column reflects the number of performance-based restricted stock units based on achievement of maximum performance, was 234% of the target grant amount for fiscal year 2024 and 240% for fiscal year 2025, rounded down to the nearest whole share. The table below reflects, for fiscal year 2024 and fiscal year 2025, the number of performance-based restricted stock units outstanding at fiscal year-end assuming achievement of target performance for the named executive officers.


Name	March 31, 2026	March 31, 2027	Total
Horacio D. Rozanski	68,114	40,169	108,283
Matthew A. Calderone	9,349	16,541	25,890
Kristine Martin Anderson	11,687	17,723	29,410
Richard C. Crowe	7,179	14,966	22,145
Nancy J. Laben	10,685	6,301	16,986

For performance-based restricted stock units granted in fiscal year 2024, vesting opportunity at grant ranged from 0-234% based on actual performance during the three-year performance period compared to the three-year cumulative Adjusted EBITDA and Revenue performance financial goals, two non-financial strategic goals, and a relative Total Shareholder Return multiplier relative to the S&P Software and Services Select Industry Index. As of the end of fiscal year 2025, the maximum vesting opportunity for this award is 222% due to the elimination of the vesting opportunity associated with one of the non-financial strategic goals, as described above in the Compensation, Discussion & Analysis. Upon a change in control, the unvested performance-based restricted stock units will be treated as set forth above under the heading "Certain Change in Control Provisions — Equity Awards."

For performance-based restricted stock units granted in fiscal year 2025, vesting opportunity ranges from 0-240% based on actual performance during the three-year performance period compared to the three-year cumulative Adjusted EBITDA and Revenue performance financial goals and a relative Total Shareholder Return multiplier relative to the S&P Software and Services Select Industry Index. Upon a change in control, the unvested performance-based restricted stock units will be treated as set forth above under the heading "Certain Change in Control Provisions — Equity Awards."

(5) The market value reported in this column has been determined based on maximum performance which is 234% and 240% of the target grant amount for both fiscal year 2024 and fiscal year 2025, respectively, rounded down to the nearest whole share, using the fair market value of our common stock on March 31, 2025 of $104.58.

Option Exercises and Stock Vested Table

The table below provides information on vesting of the restricted stock units and exercise of the stock options of each of our named executive officers during fiscal year 2025:


OPTION EXERCISES AND STOCK VESTED TABLE
	Option Awards		Stock Awards
Name	Number of Shares Acquired on Exercise (#)	Value Realized on Exercise ($)	Number of Shares Acquired on Vesting (#)1	Value Realized on Vesting 2 ($)
Horacio D. Rozanski	—	—	119,759	14,710,498
Matthew A. Calderone	—	—	13,630	1,567,171
Kristine Martin Anderson	—	—	31,249	4,011,706
Richard C. Crowe	—	—	8,367	919,566
Nancy J. Laben	—	—	19,323	2,301,931

(1)Includes performance-based restricted stock units earned by our named executive officers, as applicable, in connection with the fiscal years 2023-2025 performance period that vested on March 31, 2025 for all named executive officers and a portion of the time-based restricted stock units granted in previous fiscal years that vested on March 31, 2025 for all named executive officers as well as June 1, 2024 for Ms. Anderson.

(2)The value realized on vesting is calculated based on fair market value on the last trading day of the fiscal year, March 31, 2025, for time-based restricted stock units and fair market value on the applicable vesting date, May 20, 2025, for performance-based restricted stock units, multiplied by the number of shares of our common stock underlying such award.

Pension Benefits Table

The Officers’ Retirement Plan is an unfunded defined benefit retirement plan that we maintain for our executives. Under the Officers’ Retirement Plan, if any of the fiscal year 2025 named executive officers retire of his or her own volition (and is not entitled to severance) after a minimum of either (a) age 60 with five years of service as an executive, or (b) age 50 with 10 years of service as an executive, such executive will be entitled to receive a single lump sum retirement payment equal to $20,000 for each year of service as an executive, pro-rated as appropriate. As of fiscal year-end, all of the fiscal year 2025 named executive officers are eligible to receive benefits under the Officers’ Retirement Plan upon retirement, as shown in the table below. For a description of these benefits, see "Potential Payments upon Termination or a Change in Control — Retirement Benefits" below.


PENSION BENEFITS TABLE
Name	Plan Name	Number of Years Credited Service (#)1	Present Value of Accumulated Benefits ($)2	Payments During Last Fiscal Year ($)
Horacio D. Rozanski	Officers' Retirement Plan	25.5	510,000	—
Matthew A. Calderone	Officers' Retirement Plan	13.0	260,000	—
Kristine Martin Anderson	Officers' Retirement Plan	15.0	300,000	—
Richard C. Crowe	Officers' Retirement Plan	11.0	220,000	—
Nancy J. Laben	Officers' Retirement Plan	11.5	230,000	—

(1)The number of years of credited service is less than the named executive officer’s number of actual years of service with the Company, with the exception of Ms. Laben who was hired as an executive, as only the named executive officer’s service as an executive is relevant for purposes of the benefits available under the Officers’ Retirement Plan.

(2)The present value of accumulated benefits has been calculated in a manner consistent with our reporting of the Retired Officers’ Bonus Plan under FASB ASC 715-30, using the Accumulated Benefit Obligation with the exception of the retirement rate assumptions, as set forth in Note 14 to our financial statements included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025, which are incorporated by reference herein. The amounts shown above reflect an assumption that each participant collects his or her benefit at the earliest age at which an unreduced benefit is available.

Non-Qualified Deferred Compensation Plan Table

The following table shows information regarding the participation of our named executive officers in the Deferred Compensation Plan as of March 31, 2025


NON-QUALIFIED DEFERRED COMPENSATION PLAN TABLE
Name	Executive Contributions During Fiscal Year 2025	Company Contributions During Fiscal Year 2025	Aggregate Earnings	Aggregate Withdrawals/Distributions	Aggregate Balance at March 31, 2025
Horacio D. Rozanski	—	—	—	—	—
Matthew A. Calderone	—	—	—	—	—
Kristine Martin Anderson	—	—	—	—	—
Richard C. Crowe	—	—	$41,441	—	$868,525
Nancy J. Laben	—	—	—	—	—

Our non-qualified deferred compensation plan (or Deferred Compensation Plan) allows eligible executives to defer all or a portion of their annual bonus. Participants make an irrevocable election to defer compensation in March prior to the fiscal year in which it is earned. Amounts deferred under the Deferred Compensation Plan, as adjusted for applicable earnings gains and losses and fees, are credited to an account in the participant’s name. Contributions made to the plan are immediately vested and remain fully vested at all times. Participants may select at any time from a diversified menu of notional investment options that generally mirror the investment options of Booz Allen's ECAP plan, and the value of their Deferred Compensation Plan account balance may increase or decrease based on the performance of their selected investment options. In fiscal year 2025, the average annual return on the investment options available for the Deferred Compensation Plan was 5.6%.

Deferred Compensation Plan participants may elect to receive distributions of their deferred amounts either upon separation from service or as of a specified in-service distribution date. Distributions will be made in a lump sum payment unless the participant elects installment payments over a period between two and ten years. In case of an unforeseeable emergency that causes a severe financial hardship, the Compensation, Culture and People Committee of the Board of Directors or its designee may approve a distribution without penalty in an amount necessary to help alleviate the hardship to the extent permitted by Section 409A of the tax code. All distributions are taxable income as of the date of the withdrawal.

Potential Payments upon Termination or a Change in Control

Transition Pay

Consistent with our Transition Policy, which deals with departures other than retirement, resignation, death, disability, and terminations for cause, each named executive officer is eligible for transition pay equal to three months of base pay, as well as a lump sum payment equal to one month of base pay for each completed year as an executive, up to a maximum of nine months’ base pay. Additionally, the Company will reimburse each named executed officer for up to three months of premium costs in accordance with the Continuous Omnibus Budget Reconciliation Act, "COBRA", based on the eligible healthcare plan(s) in which the named executive officer is enrolled. Under the terms of our Transition Policy and Retirement Policy, all departure payments and benefits are contingent upon the executives’ signing of a general release.

Retirement Benefits

Under our Officers' Retirement Plan, if our named executive officers retire, they will each be entitled to receive a single lump sum retirement payment equal to $20,000 for each year of service as an executive, pro-rated as appropriate. In addition, each of our named executive officers and their eligible dependents are also entitled to receive the benefit of Company-paid retiree medical and dental coverage post-retirement.

Treatment of Equity Awards

In addition, our Equity Incentive Plan and the award agreements governing the equity awards held by our named executive officers include provisions related to the treatment of the awards upon a termination of employment:

Death

In the event of a named executive officer’s termination of employment due to death, (i) unvested options immediately vest and remain outstanding until the first anniversary of the termination date, or if earlier, the option’s expiration date, (ii) unvested time-based restricted stock units and restricted stock immediately vest, and (iii) unvested performance-based restricted stock units immediately vest at target award levels.

Disability

In the event of a named executive officer’s termination of employment due to disability, (i) unvested options continue to vest on the normal schedule, and vested options will remain outstanding until the first anniversary of the termination date (or for options vesting after the termination date, the first anniversary of the vesting date), or if earlier, the option’s expiration date, (ii) unvested time-based restricted stock units and restricted stock continue to vest on the normal schedule, and (iii) unvested performance-based restricted stock units vest on the normal vesting date in a pro rata amount of the units that would have been earned and vested based on the actual achievement of the performance goals as if employment had not terminated (with the amount prorated based on the portion of the performance period that lapsed prior to the termination date).

For Cause

In the event of a named executive officer’s termination of employment for cause (as defined in the applicable award agreement), all vested and unvested options, and all unvested time-based restricted stock units, restricted stock, and performance-based restricted stock units are immediately forfeited and canceled, effective as of the termination date.

Qualifying Permanent Retirement

If a named executive officer’s employment is terminated by reason of a qualifying permanent retirement on or after March 31 of the first fiscal year of a performance period, unvested performance-based restricted stock units will continue to vest on the vesting date based on actual achievement of the performance goals as if employment had not terminated. In the event of a retirement occurring prior to March 31 of the first fiscal year of the performance period, or if at any time if the retirement is not a qualifying permanent retirement, all unvested performance-based restricted stock units will be immediately forfeited.

Any Other Termination

In the event of a named executive officer’s termination of employment for any reason other than death, disability, a qualifying permanent retirement after the first fiscal year of a performance period (in the case of the performance-based restricted stock units), or cause, unvested options are immediately forfeited and canceled, and vested options remain outstanding until the 90th day following the termination date, or if earlier, the option’s expiration date, and unvested time-based restricted stock units and performance-based restricted stock units are immediately forfeited, in each case unless otherwise determined by our Compensation, Culture and People Committee.

Non-Competition Agreements

To the extent legally permissible, the named executive officers are party to agreements that include non-competition, non-solicitation, and non-recruitment covenants, which generally cover the period during which the executive is employed with us and for one year following termination of employment, along with perpetual confidentiality covenants. If the named executive officer breaches these agreements or otherwise engages in competitive activity as defined in the Equity Incentive Plan, the Company has the discretion to suspend vesting of all or a portion of any award and/or require the forfeiture or disgorgement to us of any equity award (including gains on the sale of the stock, if any) that vested, or was paid or settled, in the 12 months prior to, or any time after, such breach or the date the individual otherwise engaged in such competitive activity.

Change in Control Protections

We do not have change in control agreements with any of our employees.

Equity Awards

With respect to equity awards granted to our named executive officers under the Equity Incentive Plan in fiscal year 2025, pursuant to the terms of the applicable award agreements as approved by our Compensation, Culture and People Committee, in the event of a change in control, unless otherwise determined by the Compensation, Culture and People Committee or as otherwise provided in an award agreement, any unvested or unexercisable time-based and performance-based awards granted under the Equity Incentive Plan will not become fully vested upon the occurrence of a change in control, and will instead be honored, assumed or substituted following the change in control, so long as such substitute awards (i) provide a participant with rights and entitlements (including economic value) that are substantially equivalent to or better than the rights and terms applicable to the awards held by such participant immediately prior to the change in control, and (ii) provide for accelerated vesting upon an involuntary termination of a participant’s employment without cause or for good reason within two years following the occurrence of the change in control. If the awards are not honored, assumed or substituted upon a change in control, then any time-based awards granted under the Equity Incentive Plan, including time-based options and time-based restricted stock units, will fully vest, and a portion of any outstanding performance-based awards granted under the Equity Incentive Plan, including performance-based restricted stock units, will vest based on performance achieved as of the consummation of the transaction constituting a change in control.

With respect to equity awards granted to our named executive officers under the Prior Equity Incentive Plan in fiscal years 2024 and 2023, pursuant to the terms of the applicable award agreements as approved by our Compensation, Culture and People Committee, in the event of a change in control:

Retirement Benefits

The following table presents potential payments to each named executive officer as if the named executive officer’s employment had been terminated or a change in control had occurred as of the last day of fiscal year 2025. If applicable, amounts in the table were calculated using $104.58, the closing fair market value of our common stock on the last trading day of the fiscal year, March 31, 2025. The actual amounts that would be paid to any named executive officer can only be determined at the time of an actual termination of employment or change in control and would vary from those listed below.


	Severance Pay 1	Equity With Accelerated Vesting		Retirement Plan Benefits3	Death and Disability Benefits		Continued Perquisites and Benefits		Total
Name	($)	($)		($)	($)		($)		($)
Horacio D. Rozanski
Death	—	14,605,329	2	—	2,125,000	4	—		16,730,329
Disability	—	—		—	2,100,106	5	1,348,352	6	3,448,458
Involuntary Termination	1,500,000	—		—	—		67,553	7	1,567,553
Retirement 11	—	—		510,000	—		1,348,352	8	1,858,352
Voluntary Resignation	—	—		—	—		—		—
Termination for Cause	—	—		—	—		—		—
Change-In-Control	—	—		—	—		1,348,352	9	1,348,352
Qualifying Termination On or After Change-In-Control	—	14,605,329	2	—	—		—		14,605,329
Matthew A. Calderone
Death	—	4,050,230	2	—	2,062,500	4	—		6,112,730
Disability	—	—		—	2,708,114	5	1,444,739	6	4,152,853
Involuntary Termination	750,000	—		—	—		67,553	7	817,553
Retirement 11	—	—		260,000	—		1,444,739	8	1,704,739
Voluntary Resignation	—	—		—	—		—		—
Termination for Cause	—	—		—	—		—		—
Change-In-Control	—	—		—	—		1,444,739	9	1,444,739
Qualifying Termination On or After Change-In-Control	—	4,050,230	2	—	—		—		4,050,230
Kristine Martin Anderson
Death	—	5,370,288	2	—	2,075,000	4	—		7,445,288
Disability	—	—		—	2,303,875	5	1,274,320	6	3,578,195
Involuntary Termination	900,000	—		—	—		67,553	7	967,553
Retirement 11	—	—		300,000	—		1,274,320	8	1,574,320
Voluntary Resignation	—	—		—	—		—		—
Termination for Cause	—	—		—	—		—		—
Change-In-Control	—	—		—	—		1,274,320	9	1,274,320
Qualifying Termination On or After Change-In-Control	—	5,370,288	2	—	—		—		5,370,288
Richard C. Crowe
Death	—	3,561,272	2	—	2,054,167	4	—		5,615,439
Disability	—	—		—	2,095,800	5	1,320,964	6	3,416,764
Involuntary Termination	650,000	—		—	—		67,553	7	717,553
Retirement 11	—	—		220,000	—		1,320,964	8	1,540,964
Voluntary Resignation	—	—		—	—		—		—
Termination for Cause	—	—		—	—		—		—
Change-In-Control	—	—		—	—		1,320,964	9	1,320,964
Qualifying Termination On or After Change-In-Control	—	3,561,272	2	—	—		—		3,561,272
Nancy J. Laben
Death	—	2,775,344	2	—	2,054,167	4	—		4,829,511
Disability	—	—		—	1,042,291	5	1,066,284	6	2,108,575
Involuntary Termination	650,000	—		—	—		67,553	7	717,553
Retirement 11	—	—		230,000	—		1,073,641	8	1,303,641
Voluntary Resignation	—	—		—	—		—		—
Termination for Cause	—	—		—	—		—		—
Change-In-Control	—	—		—	—		1,066,284	9	1,066,284
Qualifying Termination On or After Change-In-Control	—	2,775,344	2	—	—		—		2,775,344

(1)Each named executive officer is eligible for transition pay under our Transition Policy upon an involuntary termination equal to three months of base pay, plus one additional month for each year of service as an executive, up to a maximum of nine months’ base pay.

(2)This amount for each named executive officer reflects the value of the equity awards that fully vest upon an involuntary termination of employment (i.e., a termination without "cause" or for "good reason"), on the date of a change in control or upon a named executive officer's death, calculated using $104.58, the closing fair market value of our common stock on the last trading day of the fiscal year, March 31, 2025. The accelerated vesting of these awards is described in more detail above under the heading "Change in Control Protections." In the event of a named executive officer's death, all outstanding time-based restricted stock units immediately vest and all outstanding performance-based restricted stock units immediately vest at target levels.

(3)This column represents the benefits under the Officers’ Retirement Plan, as described above under the heading "Retirement Benefits." The amounts have been calculated using the methodology and assumptions described in footnote 2 to the Pension Benefits Table above.

(4)Each named executive officer has a $2 million life insurance policy. If the death was accidental, an additional $1.5 million would be paid. Decedents' survivors also receive one month’s base pay.

(5)This amount for each named executive officer includes the present value of disability insurance payments that cover up to 60% of base salary and bonus with a maximum benefit of $25,000 per month ($300,000 per year). This amount was calculated by valuing the benefit as a standard annuity benefit based on the incidence of disability, using assumptions consistent with FASB ASC 715-30 and 715-60 accounting for our other benefit programs and, for the assumption of a rate of disability, the 1977 Social Security Disability Index table.

(6)This amount for each named executive officer includes the actuarial present value of retiree medical benefits. The present value of accumulated benefits has been calculated in a manner consistent with our reporting of the Retired Officers’ Welfare Plan under FASB ASC 715-60, using the Accumulated Post-Retirement Benefit Obligation, with an adjustment made to retirement age assumptions as required by SEC regulations.

(7)This amount for each named executive officer reflects $30,000 in outplacement assistance and three months' COBRA premiums based on healthcare eligible plan enrollments as of fiscal year end.

(8)This amount for each named executive officer represents the actuarial present value of retiree medical benefits which were calculated as described in footnote 7 above. This amount also includes the remaining book value of Ms. Laben's office furniture.

(9)This amount for each named executive officer reflects the present value of the guaranteed benefits and cash payment of the actuarial cost of the executive’s benefits under the executives’ retiree medical plan, assuming that the plan was terminated during the five years following a change in control.

(10)If the named executive officer’s employment is terminated on or after March 31, 2025 by reason of a “qualifying permanent retirement” (as defined in the applicable award agreement), outstanding unvested performance-based restricted stock units will be eligible to continue to vest on the vesting date, subject to and based on actual achievement of the performance goals. The estimated value of the continued vesting would be $26,750,623, $6,439,408, $7,308,154, $5,513,039, and $4,196,168 for Mr. Rozanski, Mr. Calderone, Ms. Anderson, Mr. Crowe and Ms. Laben, respectively, calculated based on the closing fair market value of our common stock on last trading day of the fiscal year, March 31, 2025, and assuming achievement of maximum performance levels. Upon retirement that at any time is not considered a "qualifying permanent retirement," the outstanding unvested performance-based restricted stock units will be forfeited.

Pay Ratio

In accordance with Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(u) of Regulation S-K ("Item 402(u)"), we are providing the following estimated information for fiscal year 2025:

•the annual total compensation of the median employee (excluding our CEO) was approximately $158,058, which we calculated using the same methodology we used to determine the annual total compensation of our named executive officers for fiscal year 2025 (as set forth in the Summary Compensation Table), and included base salary, any employee bonuses and awards, the Company 401(k) plan match, and the Company-paid portion of the medical and dental benefits;

•the annual total compensation of our CEO, as reported in the Summary Compensation Table, was $13,999,139; and

•the ratio of the annual total compensation of our CEO to the median of the annual total compensation of all our other employees (the "Pay Ratio") was approximately 89 to 1.

The Pay Ratio is a reasonable estimate calculated in a matter consistent with Item 402(u). Additionally, the rules for identifying the "median employee" and calculating the Pay Ratio allow companies to apply various methodologies and assumptions. As a result, the compensation for our median employee and the Pay Ratio reported by us should not be used as a comparison to the information reported by other companies.

Methodology for Identifying Our "Median Employee"

We determined that as of March 31, 2025 our total employee population consisted of approximately 35,665 individuals, including our CEO, and both full-time and part-time employees, of which approximately 34,566 were aligned to offices in the United States or U.S. jurisdictions, and 1,099 to offices in non-U.S. jurisdictions. As the population of employees located in non-U.S. jurisdictions accounts for less than 5% of our total workforce, we were able to rely on the de minimis exception permitted under Item 402(u) and exclude the non-U.S. population from our "median employee" calculation, which included employees located in Australia (11), Belgium (8), Brazil (1), Djibouti (3), Eswatini (1), Germany (532), Guatemala (1), Italy (26), Japan (168), Republic of Korea (47), Kosovo (2), Lithuania (1), Netherlands (12), Pakistan (29), Poland (2), Romania (1), Kingdom of Saudi Arabia (4), Serbia (1), Singapore (6), Spain (1), and the United Kingdom (242). After excluding the non-U.S. population, our CEO, and employees on unpaid leave of absence for the full fiscal year 2025, the resulting adjusted employee population to be used for identifying our "median employee" was 34,565.

We compared the annual salary of our adjusted employee population as reflected in our human resources system of record. This measure was consistently applied to all individuals in the adjusted employee population. This analysis yielded our median salary which identified a single individual, for whom we performed a detailed analysis of the annual total compensation, as discussed below.

Annual Total Compensation Determination

We calculated annual total compensation using the same methodology we used for purposes of determining the annual total compensation of our named executive officers for fiscal year 2025 (as set forth in the Summary Compensation Table). Specifically, in addition to the actual salary paid for fiscal year 2025, the calculation of total compensation for our "median employee" included Company-paid portions of health and wellness benefits and qualified retirement plan contributions.

Pay Versus Performance

This Pay Versus Performance (or "PvP") section, along with corresponding tables, has been written in compliance with Item 402(v) of Regulation S-K under the Exchange Act. Compensation Actually Paid (or "CAP") to our named executive officers in each of fiscal years 2021 through 2025 has been calculated in accordance with such PvP rules and is compared below with specific performance measures as required by the rules.

Performance Measures

In accordance with the PvP rules, the most important performance measures we use to link CAP to our named executive officers for fiscal year 2025 to our performance are listed in the table below. These metrics are not in rank order. Under the "Annual Cash Incentive" and "Long-term Equity Incentives" titles in the "Compensation Discussion and Analysis" section of this proxy statement, each of these performance measures is described in depth.


Metric			Metric Type
Adjusted EBITDA			Financial Measure
Revenue			Financial Measure
Capital Deployment for M&A			Strategic Measure
Platform Growth			Strategic Measure

Pay Versus Performance Table

The CAP figures in the table below do not represent the compensation that the CEO or the NEOs actually earned, realized or received due to the change in fair value of the equity awards over time. As a result, when designing or deciding on the compensation for our NEOs, the Compensation, Culture and People Committee did not take the data in the table into account. Our "Compensation Discussion and Analysis" includes a thorough explanation of the Company's executive pay program and the guiding principles and methodology of the Committee (beginning on page 29).


					Value of Initial Fixed $100 Investment Based On:
Fiscal Year (7)	Summary Compensation Table Total for PEO ($)(000) (1)(2)	Compensation Actually Paid to PEO ($)(000) (1)(3)(4)(5)	Average Summary Compensation Table Total for Non-PEO NEOs ($)(000) (1)(2)	Average Compensation Actually Paid to Non-PEO NEOs ($)(000) (1)(3)(4)(5)	BAH Total Shareholder Return ($)	S&P Software & Services Select Industry Index Total Shareholder Return ($)(6)	Net Income ($)(000)(8)	Adjusted EBITDA ($)(000) (9)
2025	13,999	(2,718)	5,890	2,563	166	198	935,030	1,315,031
2024	15,594	48,237	3,691	8,555	232	192	605,706	1,175,064
2023	12,184	16,036	3,673	2,879	142	152	271,215	1,014,065
2022	11,866	9,938	3,125	3,019	132	181	466,577	935,088
2021	8,355	14,801	3,147	5,097	119	192	608,958	839,674

(1)Horacio D. Rozanski is our principal executive officer (PEO) for fiscal years 2021, 2022, 2023, 2024, and 2025. The individuals comprising the non-PEO named executive officers (“Non-PEO NEOs”) for each year presented are listed below.

2021

2022

2023

2024

2025

Lloyd W. Howell, Jr.

Matthew A. Calderone

Karen M. Dahut

Kristine Martin Anderson

Nancy J. Laben

Judith H. Dotson

Richard C. Crowe

Susan L. Penfield

Nancy J. Laben

Karen M. Dahut

Lloyd W. Howell, Jr.

(2)Amounts shown for "Summary Compensation Table" total for each applicable fiscal year (i) for the PEO, are the amounts of total compensation as reported in the Summary Compensation Table for the PEO, and (ii) for the Non-PEO NEOs, are the average of the amounts of total compensation as reported in the Summary Compensation Table for such Non-PEO NEOs. Amount shown for fiscal year 2024 has been updated this year to account for a correction to the All Other Compensation amount reported for Ms. Laben in the Summary Compensation Table in our prior year’s proxy, as described in footnote 6 to the Summary Compensation Table above.

(3)Amounts shown for CAP are computed in accordance with Item 402(v) of Regulation S-K under the Exchange Act and do not reflect the actual amount of compensation earned by or paid to the NEOs during the applicable year. These amounts reflect total compensation for the PEO and average total compensation for Non-PEO NEOs as reported in the Summary Compensation Table, with certain adjustments as required by Item 402(v) of Regulation S-K and described in footnote (5) below.

(4)For the portion of CAP that is based on year-end stock prices, $104.58 was used for fiscal year 2025, $148.44 was used for fiscal year 2024, $92.69 was used for fiscal year 2023, $87.84 was used for fiscal year 2022, and $80.53 was used for fiscal year 2021.

(5)CAP reflects the exclusions and inclusions of certain amounts from Summary Compensation Table total compensation for the PEO and the Non-PEO NEOs as set forth below under the heading "Summary Compensation Table Total and Compensation Actually Paid Reconciliation for the PEO and Non-PEO NEOs." Equity values are calculated in accordance with FASB ASC Topic 718, Compensation — Stock Compensation. The valuation methodologies and assumptions used to calculate the equity values included in CAP are based on our grant date fair value of the equity awards as disclosed in the Company’s consolidated audited financial statements filed with the SEC on Form 10-K for the applicable fiscal year, with the adjustments set forth below in the "Summary Compensation Table Total and Compensation Actually Paid Reconciliation for the PEO and Non-PEO NEOs" table.

(6)Total stockholder return ("TSR") shown in the table above utilizes the S&P Software & Services Select Index which we use in the stock performance graph required by Item 201(e) of Regulation S-K included in the Company’s consolidated audited financial statements filed with the SEC on Form 10-K for fiscal years 2021, 2022, 2023 2024 and 2025. The comparison of TSR assumes that $100 was invested for the period starting April 1, 2020 through March 31 of the applicable fiscal year in each of the Company’s Common Stock and the S&P Software & Services Select Index. All dollar values assume reinvestment of the pre-tax value of dividends paid by companies included in the S&P Software & Services Select Index. The historical stock price performance of our Common Stock shown is not necessarily indicative of future stock price performance.

(7)Amounts shown represent the amount of net income reflected in the Company's audited financial statements filed with the SEC on Form 10-K for the applicable fiscal year.

(8)Pursuant to Item 402(v) of Regulation S-K, we determined annual Adjusted EBITDA to be our most important financial performance measure used to link Company performance to CAP to our PEO and other Non-PEO NEOs in fiscal year 2025. See Appendix A to this proxy statement for a reconciliation of Adjusted EBITDA to the most directly comparable financial measure calculated and presented in accordance with GAAP. Annually, we review our established performance financial metrics to ensure they maximize stockholder value. As such, we may determine a different financial performance measure in future years.

(9)Values shown for 2024 have been adjusted to reflect actual other summary compensation table amounts after the completion of the prior year's disclosure for Non-PEO NEOs.

Summary Compensation Table Total and Compensation Actually Paid Reconciliation for the PEO and Non-PEO NEOs

The following table sets forth the adjustments that were made to Summary Compensation Table ("SCT") total compensation to calculate CAP to our PEO and the average CAP to our Non-PEO NEOs for each of the years in the PvP table above. Although the table below includes SCT compensation and CAP totals, the values are not comparable. The SCT values include base salary, short term annual cash incentive, and long-term equity incentives, and all other compensation received by the PEO and Non-PEO NEOs during the applicable fiscal year. The long-term equity incentive values for each year in the SCT are calculated by using the fair value of the grant at the time the grant was made. CAP values include a revaluation of the grants made during fiscal year 2025 at fiscal year-end, plus the fiscal year-over-year change in the fair value of multiple fiscal years of historical equity grants. CAP may be higher or lower than the SCT compensation values because CAP includes multiple fiscal years of grants and the calculation of CAP each year is heavily impacted by the change in the Company's stock price. The actual value of an equity award realized by the PEO or a Non-PEO NEO depends on several factors measured over multiple fiscal years to include but not limited to the Company's stock price, the financial performance of the Company, the relative TSR performance of the Company as compared to a peer group, and timing of stock option exercises.


	Calculation for PEO		Calculation for Average of Non-PEO NEOs
Calculation of Compensation Actually Paid	Fiscal Year 2024($)	Fiscal Year 2025($)	Fiscal Year 2024($)	Fiscal Year 2025($)
SCT Total Compensation	15,593,759	13,999,139	3,690,653	5,889,962
Less aggregate change in actuarial present value of accumulated pension benefits	(255,000)	(20,000)	(150,000)	(20,000)
Less aggregate grant date fair value of stock and option awards in SCT	(10,406,766)	(10,531,335)	(1,624,853)	(4,333,893)
Less fair value at the end of the prior fiscal year for any awards granted in any prior fiscal year that fail to meet the applicable vesting conditions during the covered fiscal year	—	—	—	—
Plus fair value as of fiscal year-end of awards granted during the fiscal year that are outstanding and unvested as of the end of the fiscal year	25,641,393	6,278,570	3,961,798	2,487,616
Plus fair value as of vesting date of awards that are granted and vest in the same year	2,136,645	887,780	344,158	465,616
Plus change in fair value (whether positive or negative) as of fiscal year-end for awards granted in prior fiscal years that are unvested and outstanding as of the end of the fiscal year	6,930,943	(8,612,420)	1,366,960	(1,481,346)
Plus change in fair value (whether positive or negative) as of vesting date (from the end of the prior fiscal year) of awards granted in prior fiscal years for which all applicable vesting conditions were satisfied at fiscal year-end or during the fiscal year	7,793,303	(5,217,476)	854,025	(520,044)
Plus dollar value of any dividends or other earnings paid on awards during the fiscal year prior to the vesting date that are not otherwise included in total compensation for the covered fiscal year	802,607	498,012	112,558	74,649
Compensation Actually Paid	48,236,884	(2,717,730)	8,555,299	2,562,560

Relationship Between Pay Versus Performance Measures and Compensation Actually Paid Descriptions

The charts below display the relationship between CAP to our PEO and the average of CAP to our other NEOs in each of fiscal years 2021 through 2025, and (i) the Company’s cumulative TSR and S&P Software & Services Select Industry Index cumulative TSR, (ii) the Company's GAAP Net Income, and (iii) Adjusted EBITDA over the four-year period from fiscal years 2021 through 2025. For a discussion of how the Compensation, Culture and People Committee assessed the Company's performance and our NEOs' pay each year, see "Compensation Discussion and Analysis" in this Proxy Statement and in the proxy statements for fiscal years 2025, 2024, 2023, 2022 and 2021.

COMPENSATION COMMITTEE REPORT

The Compensation, Culture and People Committee has reviewed and discussed the CD&A included in this proxy statement with members of management, and based on such review and discussions, the Compensation, Culture and People Committee recommended to the Board that the CD&A be included in this proxy statement.

THE COMPENSATION, CULTURE AND PEOPLE

COMMITTEE

Gretchen W. McClain (Chair)

Melody C. Barnes

Michèle A. Flournoy

Rory P. Read

William M. Thornberry

AUDIT COMMITTEE REPORT

The Audit Committee is composed of five directors identified below, each of whom is an independent director as defined by the applicable SEC rules and the NYSE listing standards. Four committee members, Joan Amble, Debra L. Dial, Ellen Jewett, and Charles O. Rossotti, have been designated by the Board as “audit committee financial experts” under applicable SEC rules. For further description of each committee member’s background and expertise, please refer to the director qualification section of our proxy statement beginning on page 7.

The Audit Committee is responsible for assisting the Board in fulfilling its oversight responsibilities relating to, among other things, the Company’s accounting, auditing, and financial reporting processes, internal controls, compliance with legal and regulatory requirements and its code of ethics, and risk management, as discussed more fully in the Audit Committee charter, a copy of which is available on our website, www.boozallen.com. In accordance with its charter, the Audit Committee appoints the Company’s independent registered public accounting firm, E&Y, subject to stockholder ratification, and conducts an annual review of its performance. In addition, the Audit Committee pre-approves all audit and permissible non-audit services provided by E&Y, and the fees for those services. The Audit Committee also oversees the Company’s internal audit function, including its annual audit plan, budget, and staffing. As part of its oversight role, the Audit Committee meets throughout the year, separately and together, with each of management, the Company's internal auditors, and E&Y.

Management has the primary responsibility for the Company's financial statements and accounting and reporting processes, including the systems of internal accounting control. E&Y is responsible for performing an independent audit of the consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board (“PCAOB”), and rendering opinions on whether the financial statements are in conformity with accounting principles generally accepted in the United States and the effectiveness of the Company’s internal control over financial reporting.

The Audit Committee has reviewed and discussed with management of the Company and E&Y, the audited consolidated financial statements of the Company for the fiscal year ended March 31, 2025 (the “Audited Financial Statements”), and their assessment of the effectiveness of internal control over financial reporting. The Audit Committee also reviewed any significant audit findings identified by E&Y, and those identified by the Company's internal auditors as well as management's responses thereto. In addition, the Audit Committee discussed with E&Y the matters required to be discussed by the applicable requirements of the PCAOB and the SEC.

The Audit Committee has also: (i) considered whether non-audit services provided by E&Y are compatible with its independence; (ii) received the written disclosures and the letter from E&Y required by the applicable requirements of the PCAOB regarding E&Y’s communications with the Audit Committee concerning independence; and (iii) discussed with E&Y its independence.

Based on the reviews and discussions described above, the Audit Committee recommended to the Board that the Audited Financial Statements be included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2025 for filing with the SEC.

THE AUDIT COMMITTEE

Ellen Jewett (Chair)

Joan Lordi C. Amble

Debra L. Dial

Arthur E. Johnson

Charles O. Rossotti

PRE-APPROVAL OF SERVICES BY
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Audit Committee pre-approves all audit, audit-related, tax, and other services performed by our independent auditors. The Audit Committee pre-approves specific categories of services up to pre-established fee thresholds. Unless the type of service had previously been pre-approved, the Audit Committee must approve that specific service before the independent auditors may perform it. In addition, separate approval is required if the amount of fees for any pre-approved category of service exceeds the fee thresholds established by the Audit Committee. The Audit Committee has delegated to the chair of the committee pre-approval authority with respect to permitted services, provided that the chair must report any pre-approval decisions to the Audit Committee at its next scheduled meeting. All fees described below were pre-approved by the Audit Committee.

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FEES

The following table presents the Company’s fees for services performed by its principal accounting firm, E&Y, during fiscal years 2025 and 2024.


(Amounts in thousands)	2025		2024
Audit fees(1)	$	4,762	$	4,070
Audit-related fees	33		32
Tax fees(2)	36		49
All other fees(3)	10		10
Total	$	4,841	$	4,161

(1)Audit fees principally include those for services related to the audit and quarterly reviews of the Company’s consolidated financial statements and consultation on accounting matters.

(2)Tax fees principally include domestic and foreign tax compliance and advisory services.

(3)All other fees consists of fees not reported under the categories above and primarily includes fees for accounting research software.

PROPOSAL 2: RATIFICATION OF APPOINTMENT OF ACCOUNTANTS

The Audit Committee has appointed E&Y as the independent auditors to perform an integrated audit of the Company for the fiscal year ending March 31, 2026. E&Y served as our independent auditors for the fiscal year ended March 31, 2025. Stockholder approval of the appointment is not required.

The Board believes that obtaining stockholder ratification of the appointment is a sound corporate governance practice. If the stockholders do not vote on an advisory basis in favor of E&Y, the Audit Committee will reconsider whether to hire the firm and may retain E&Y or hire another firm without resubmitting the matter for stockholders to approve. The Audit Committee retains the discretion at any time to appoint a different independent auditor.

Representatives of E&Y are expected to be present at the Annual Meeting, available to respond to appropriate questions, and will have the opportunity to make a statement if they desire.


The Board of Directors recommends a vote FOR ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for fiscal year 2026.

PROPOSAL 3: ADVISORY VOTE ON COMPANY'S EXECUTIVE COMPENSATION

As required by Section 14A of the Exchange Act, the Company is providing stockholders with a non-binding advisory vote on the compensation of our named executive officers, as disclosed in the CD&A, the accompanying compensation tables, and the related narrative disclosure in this proxy statement. Although this vote is advisory, the Board and the Compensation, Culture and People Committee value the opinions of our stockholders and will review and consider the voting results when making future compensation decisions for our named executive officers.

As described in detail in the CD&A, our compensation programs are designed to attract, motivate, and retain executives of outstanding ability to meet and exceed the demands of our customers, focus management on optimizing stockholder value and fostering an ownership culture, create appropriate rewards for outstanding performance and penalties for underperformance, and provide competitive rewards that foster collaboration by rewarding executives for their contribution to our overall performance and financial success while determining and allocating incentives based on our performance as a whole in recognition of the spirit and culture of collaboration that has defined us throughout our history. Accordingly, the Board submits the following resolution for a stockholder vote at the 2025 Annual Meeting of Stockholders:

RESOLVED, that the stockholders approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the CD&A, the accompanying compensation tables, and the related narrative disclosure in the Company’s proxy statement for the 2025 Annual Meeting of Stockholders.


The Board of Directors recommends a vote FOR the approval, on an advisory basis, of the compensation of our named executive officers as disclosed in the Compensation Discussion and Analysis of this proxy statement.

PROPOSAL 4: STOCKHOLDER PROPOSAL

The Company has been informed that John Chevedden, 2215 Nelson Avenue, No. 205, Redondo Beach, CA, 90278, a beneficial owner of shares of our Class A common stock having a minimum value as set forth in Rule 14a-8 of the Exchange Act allowing submission of proposals by stockholders meeting certain requirements, intends to present the proposal set forth below at our Annual Meeting (the “Stockholder Proposal”). Mr. Chevedden has owned 50 shares of our Class A common stock since November 20, 2021. The Stockholder Proposal will be voted on at the Annual Meeting only if properly presented by or on behalf of Mr. Chevedden. In accordance with federal securities laws, the proposed stockholder proposal is presented verbatim from his submission. The Company disclaims all responsibility for the content of the resolution and the supporting statement, including other sources referenced in the supporting statement.

For the reasons stated in the Board of Directors’ Statement in Opposition, which follows the Stockholder Proposal, the Board recommends that you vote “AGAINST” the Stockholder Proposal.

Stockholder Proposal

Proposal 4 - Support for Transparency in Political Spending

Resolved, Shareholders request that Booz Allen (BAH) provide a report, updated semiannually, disclosing the Company's:

1.Policies and procedures for making, with corporate funds or assets, contributions and expenditures (direct or indirect) to (a) participate or intervene in any campaign on behalf of (or in opposition to) any candidate for public office, or (b) influence the general public, or any segment thereof, with respect to an election or referendum.

2.Monetary and non-monetary contributions and expenditures (direct and indirect) used in the manner described in section 1 above, including:

a.The identity of the recipient as well as the amount paid to each; and

b.The title(s) of the person(s) in the Company responsible for decision-making.

The report shall be presented to the board of directors or relevant board committee and posted on the Company's website within 12 months from the date of the annual meeting. This proposal does not encompass lobbying spending.

Supporting Statement

Long-term BAH shareholders support transparency and accountability in corporate electoral spending. A company's reputation, value, and bottom line can be adversely impacted by political spending. The risk is especially serious when giving to trade associations, Super PACs, 527 committees, and "social welfare" organizations - groups that routinely pass money to or spend on behalf of candidates and political causes that a company might not otherwise wish to support.

The Conference Board's 2021 "Under a Microscope" report warns "Political activity can pose increasingly significant risks for companies, including the perception that political contributions-and other forms of activity - are at odds with core company values." Further, a recent poll of retail shareholders by Mason-Dixon Polling & Research found that 83% of respondents said they would have more confidence investing in corporations that have adopted reforms that provide for transparency and accountability in political spending.

BAH scored 18% out of 100% in the 2024 CPA-Zicklin Index of Corporate Political Disclosure and Accountability:

https://www.politicalaccountability.net/wp-content/uploads/2025/01/2024-CPA-Zicklin-Index.pdf

This proposal asks BAH to disclose all of its electoral spending, including payments to Trade Associations and 501(c)(4) social welfare organizations, which may be used for electoral purposes - and are otherwise undisclosed. This would bring BAH in line with a growing number of leading companies, including, Cognizant Technology Solutions Corp., Boeing and RTX Corporation which present this information on their websites.

Without knowing the recipients of our company's political dollars we cannot sufficiently assess whether our company's election-related spending aligns or conflicts with its policies on climate change and sustainability, or other areas of concern. Improved BAH political spending disclosure will protect the reputation of BAH and preserve shareholder value.

Board of Directors’ Statement in Opposition

The Board of Directors has carefully considered the Stockholder Proposal and believes that it is not in the best interests of the Company’s stockholders for the reasons outlined below. Accordingly, the Board recommends a vote “AGAINST” the Stockholder Proposal.

Existing Transparency and Accountability

The Company is committed to transparency and is committed to making appropriate disclosures with respect to participation in U.S. political and lobbying activities. As a Company, Booz Allen does not make:

•financial contributions to any political party, committee, or candidate for federal office,

•independent political expenditures in direct support of, or in opposition to, campaigns, or

•payments to influence the outcome of ballot measures.

The Company has recently decided to publish our reports on political spending and trade association memberships as well as our enhanced Political Activities Statement to ensure stockholders are well-informed about the Company's political activities. The Company intends to update these reports on an annual basis. The Company's Political Activity Statement and reports on political spending and trade association memberships are publicly available on each of the Ethics & Compliance and Investor Relations portions of the Company's website at www.boozallen.com.

The Political Activities Statement generally sets forth the Company's policies and practices with respect to lobbying and political activities, political contributions and trade association memberships.

The Company's reports on political spending and trade association memberships provide details on the Company's corporate payments which may be used for political purposes, including whether payments were made to political candidates and parties and tax-exempt political organizations, as well as payments to U.S. trade associations where membership dues were equal to or greater than $50,000 and the non-deductible portion of such dues as reported by the relevant trade association.

The Booz Allen Hamilton Inc. Political Action Committee (the "Booz Allen PAC") is a voluntary, nonpartisan organization that operates in accordance with U.S. campaign finance laws as well as its own bylaws and policies, and its disbursements are entirely funded by voluntary, personal contributions from eligible Booz Allen employees and family members, members of the Company Board of Directors, and Company stockholders. The Booz Allen PAC is managed and governed by a board of directors, which is chaired by the Head of Government Relations and made up of leaders from across the Company. Additional information regarding the Booz Allen PAC may be found in the Company's Political Activities Statement, which is publicly available on each of the Ethics & Compliance and Investor Relations portions of the Company's website at www.boozallen.com.

Robust Compliance Program

The Company maintains a robust compliance program and system of internal controls designed to ensure that its political and lobbying activities are conducted and disclosed in compliance with applicable laws and Company policy, including quarterly reporting of lobbying activities and expenses to Congress. In addition, periodically, and at least annually, our Head of Government Relations updates the Company's Board of Directors on the Company’s political and lobbying activities.

Unnecessary Reporting Requirements

The Board believes that the Stockholder Proposal is unnecessary, redundant and would not deliver any commensurate benefit or value to stockholders. As described above, the Company already provides comprehensive disclosures regarding its political activities and certain corporate contributions, and there is considerable overlap between the information requested by the Stockholder Proposal and the Company's existing disclosures. Accordingly, the Board has determined that the adoption of the Stockholder Proposal would merely create unnecessary complexity and administrative cost without offering any tangible improvement or added value for our stockholders.

Alignment with Industry Practices

The Board believes that the Company’s current practices are in line with industry standards and the practices of other leading companies. The Company engages in U.S. political and lobbying activities in ethical and responsible ways to advocate for the Company’s business interests. The Company also maintains memberships in industry groups and trade associations in support of our strategic business objectives.

To further illustrate how our current policies already implement the proposal, the following chart shows the principal aspects of the proposal and how the Company is fulfilling each:


Stockholder Proposal Requests			Action Taken by Booz Allen
The Company provides a report, updated semiannually, that is presented to the board of directors or relevant board committee and posted on the Company’s website.			•Beginning in June 2025, the Company posted on our website at www.boozallen.com, reports on political spending and trade association memberships. The Company intends to update these reports annually. •The Company's reports on political spending and trade association memberships are approved by the Nominating and Corporate Governance Committee of the Board of Directors on an annual basis. The Company believes an annual frequency strikes the appropriate balance between transparency and use of Company resources and is consistent with industry practice.
Disclose the policies and procedures for making, with corporate funds or assets, contributions and expenditures (direct or indirect) to participate or intervene in any campaign on behalf of (or in opposition to) any candidate for public office.			•Booz Allen does not make political contributions or expenditures. •Our Political Activities Statement and reports on political spending and trade association memberships are available on our website at www.boozallen.com.
Disclose the policies and procedures for making, with corporate funds or assets, contributions and expenditures (direct or indirect) to influence the general public, or any segment thereof, with respect to an election or referendum.			•Booz Allen does not make political contributions or expenditures. •Our Political Activities Statement and reports on political spending and trade association memberships are available on our website at www.boozallen.com.
Disclose the monetary and non-monetary contributions and expenditures (direct and indirect) used to participate or intervene in any campaign on behalf of (or in opposition to) any candidate for public office, including: the identity of the recipient as well as the amount paid to each; and the title(s) of the person(s) in the Company responsible for decision-making.			•Booz Allen does not make political contributions or expenditures. •The Company posts on its website reports on political spending, including whether payments were made to tax-exempt political organizations as well as U.S. trade association membership dues of at least $50,000 made by the Company and the non-deductible portion of such dues as reported by the relevant trade association. The Company intends to update these reports annually. •The Company believes this threshold for trade association membership dues provides appropriate transparency of the payments most relevant to our stockholders. Disclosure of trade association dues below this threshold would create unnecessary administrative burdens and would not provide decision-useful information to our stockholders.
Disclose the monetary and non-monetary contributions and expenditures (direct and indirect) used to influence the general public, or any segment thereof, with respect to an election or referendum, including: the identity of the recipient as well as the amount paid to each; and the title(s) of the person(s) in the Company responsible for decision-making.			•Booz Allen does not make political contributions or expenditures. •The Company posts on its website reports on political spending, including whether payments were made to tax-exempt political organizations as well as U.S. trade association membership dues of at least $50,000 made by the Company and the non-deductible portion of such dues as reported by the relevant trade association. The Company intends to update these reports annually. •The Company believes this threshold for trade association membership dues provides appropriate transparency of the payments most relevant to our stockholders. Disclosure of trade association dues below this threshold would create unnecessary administrative burdens and would not provide decision-useful information to our stockholders.

Conclusion

The Board does not believe that it is in the best interests of the Company or its stockholders to approve the Stockholder Proposal. Because the Company recently enhanced its disclosures regarding its political activities and certain corporate

payments, and because there is considerable overlap between the information requested by the Stockholder Proposal and these disclosures, the proposal would not provide additional meaningful information or benefit to stockholders and would impose undue costs and administrative burdens on the Company.

Required Vote and Recommendation

Approval of this proposal requires the affirmative vote of a majority of the shares entitled to vote at the Annual Meeting represented either in person or by proxy at the Annual Meeting.


The Board of Directors recommends a vote AGAINST the Stockholder Proposal.

OTHER BUSINESS

The Board is not aware of any other matters to be presented at the Annual Meeting. If any other matter proper for action at the meeting should be presented, the holders of the accompanying proxy will vote the shares represented by the proxy on such matter in accordance with their best judgment. If any matter not proper for action at the meeting should be presented, the holders of the proxy will vote against consideration of the matter or the proposed action.

By order of the Board of Directors,

Jacob D. Bernstein

Secretary

McLean, Virginia

June 12, 2025

IMPORTANT INFORMATION ABOUT ANNUAL MEETING AND PROXY PROCEDURES

The Board is soliciting proxies to be used at the Annual Meeting of Stockholders to be held virtually on July 23, 2025, beginning at 8:00 a.m. (EDT) at www.virtualshareholdermeeting.com/BAH2025.

Why am I receiving these proxy materials?

You have received these proxy materials because our Board is soliciting your proxy to vote your shares at the Annual Meeting. As a stockholder, you are invited to attend the Annual Meeting and are requested to vote on the items of business described in this proxy statement. This proxy statement includes information that we are required to provide to you under SEC rules, and describes issues on which we would like you to vote at our Annual Meeting. It also gives you information on these issues so that you can make an informed decision. The proxy materials include our proxy statement for the Annual Meeting, our annual report to stockholders, which includes our Annual Report on Form 10-K for the year ended March 31, 2025 and the proxy card, or a voting instruction card, for the Annual Meeting.

Our Board has made this proxy statement and proxy card available to you on the Internet because you own shares of Class A common stock of the Company.

If you submit a proxy by using the Internet, by calling, or by signing and returning the proxy card, you will appoint Horacio D. Rozanski, Chairman, Chief Executive Officer, and President, and Jacob Bernstein, Deputy General Counsel and Secretary, (with full power of substitution) as your representatives at the Annual Meeting. They will vote your shares at the Annual Meeting as you have instructed them or, if an issue that is not on the proxy card comes up for vote, in accordance with their best judgment. By submitting a proxy, you can ensure your shares will be voted whether or not you attend the Annual Meeting. Even if you plan to attend the Annual Meeting, we encourage you to submit a proxy in advance by using the Internet, by calling, or by signing and returning your proxy card. If you vote by Internet or by calling, you do not need to return your proxy card.

Why did I receive a one-page notice in the mail regarding the Internet availability of proxy materials instead of a full set of proxy materials?

Pursuant to the "Notice and Access" rules adopted by the SEC, we have elected to provide access to our proxy materials over the Internet at www.proxyvote.com. Accordingly, we are sending a Notice of Internet Availability of Proxy Materials to our stockholders. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice of Internet Availability of Proxy Materials, or request to receive an electronic copy or printed set of the proxy materials. Instructions on how to access the proxy materials over the Internet or to request an electronic copy or printed copy may be found in the Notice of Internet Availability of Proxy Materials. In addition, stockholders may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis by submitting a request in writing to our Secretary at Booz Allen Hamilton, 8283 Greensboro Drive, McLean, Virginia 22102. We encourage stockholders to take advantage of the availability of proxy materials on the Internet to help reduce the environmental impact and cost of the Annual Meeting.

How can I sign up for the electronic proxy delivery service?

You can elect to receive an email that provides a link to our future proxy materials on the Internet. The proxy card or the instructions that accompanied your proxy materials will contain instructions on how to request electronic delivery of future proxy materials. Choosing to receive your future proxy materials by email will eliminate the cost of printing and mailing documents and will reduce the associated environmental impact. If you choose to receive future proxy materials by email, you will receive an email next year with instructions containing a link to those materials and a link to the proxy voting site. Your election to receive proxy materials by email will remain in effect until you terminate it.

How do I attend and participate in the virtual Annual Meeting?

You will be able to virtually attend the Annual Meeting by visiting www.virtualshareholdermeeting.com/BAH2025. Although it will be a virtual-only meeting, the Company wants to assure its stockholders of its commitment to ensuring that the Annual Meeting provides its stockholders with the same rights and opportunities to participate as in an in-person meeting, including the ability to ask questions of the Board and management.

To participate in the Annual Meeting, you will need the control number located on your proxy card or the instructions that accompanied your proxy materials. The Annual Meeting will begin promptly at 8:00 a.m. Eastern Time on July 23, 2025.

We encourage you to access the virtual meeting website prior to the start time. Online check-in will begin at 7:45 a.m. Eastern Time, and you should allow ample time to ensure your ability to access the meeting.

You may submit a question during the meeting by visiting www.virtualshareholdermeeting.com/BAH2025 and following the instructions on the website. The Company will post responses to questions relevant to meeting matters that are not answered during the Annual Meeting due to time constraints on the Company's Investor Relations portion of our website at investors.boozallen.com, as soon as practicable after the Annual Meeting. The Chair of the meeting has broad authority to conduct the Annual Meeting in an orderly manner, including establishing rules of conduct. A copy of the rules of conduct will be available online at the Annual Meeting.

In addition, the Company will have technicians ready beginning fifteen minutes prior to the meeting to assist participating stockholders with any technical difficulties they may have accessing the virtual meeting. If participating stockholders encounter any difficulties accessing the virtual meeting during check-in or the meeting, they may call the technical support number that will be posted on the virtual meeting platform log-in page.

Who is entitled to vote at the Annual Meeting?

Holders of the Company’s Class A common stock are entitled to vote at the Annual Meeting. The Board has established the record date for the Annual Meeting as June 2, 2025. Only holders of record of the Company’s Class A common stock on the record date are entitled to receive notice of the meeting and to vote at the meeting. Dissenters’ rights are not applicable to any of the matters being voted upon at the Annual Meeting.

How many shares must be present to hold the Annual Meeting?

In order for us to lawfully conduct business at the Annual Meeting, the holders of stock representing a majority of the voting power of all shares issued and outstanding and entitled to vote at the meeting must be present in person at the Annual Meeting or represented by proxy. This is referred to as a quorum. Stockholders who attend the Annual Meeting online at www.virtualshareholdermeeting.com/BAH2025 will be deemed to be in person attendees for purposes of determining if a quorum has been met. If a quorum is present, we can hold the Annual Meeting and conduct business.

How many shares may I vote?

On June 2, 2025, 124,081,853 shares of our Class A common stock were outstanding. Each share of Class A common stock is entitled to one vote, and stockholders do not have the right to cumulate their votes for the election of directors.

What am I voting on and what are the Board’s recommendations?


Proposal	Description	Board's Voting Recommendation	Page Reference
No. 1	Election of twelve director nominees	FOR each nominee	7
No. 2	Ratification of appointment of E&Y as the Company's independent registered accounting firm for fiscal year 2026	FOR	64
No. 3	A non-binding advisory vote on the compensation program for the Company’s named executive officers, as disclosed in the CD&A of the proxy statement	FOR	65
No. 4	If properly presented at the Annual Meeting, a non-binding advisory vote on a stockholder proposal	AGAINST	66

What is the difference between holding shares as a stockholder of record and as a beneficial owner?

If your shares are registered directly in your name with the Company’s registrar and transfer agent, Computershare, you are considered a “stockholder of record” with respect to those shares. In this case, we are sending the Notice of Internet Availability of Proxy Materials to you directly.

If your shares are held in a brokerage account or bank, you are considered the “beneficial owner” of those shares, which are held in “street name.” In this case, the Notice of Internet Availability of Proxy Materials will be forwarded to you by your broker or bank. As the beneficial owner, you have the right to direct your broker or bank how to vote your shares by following the voting instructions noted below.

What is the procedure for voting?

If you are a stockholder of record of Class A common stock, you can vote your shares at the Annual Meeting by attending the virtual meeting using the control number located on your proxy card, or the instructions that accompanied your proxy

materials and submitting an electronic ballot, or you can give a proxy to be voted at the Annual Meeting in one of three ways: (1) over the telephone by calling a toll-free number provided on the enclosed proxy card, (2) electronically via the Internet as described in the enclosed proxy card, or (3) date, sign, and complete the proxy card and return it in the enclosed envelope, which requires no postage stamp if mailed in the United States.

If you are a beneficial owner of Class A common stock, you must obtain a proxy, executed in your favor, from the stockholder of record to be able to vote virtually at the Annual Meeting. You can vote your shares at the Annual Meeting by attending the virtual meeting using the control number located on your proxy card, or the instructions that accompanied your proxy materials and submitting an electronic ballot, or you can give a proxy to be voted at the Annual Meeting in one of three ways: (1) over the telephone by calling a toll-free number provided on the enclosed proxy card, (2) electronically via the Internet as described in the enclosed proxy card, or (3) date, sign, and complete the proxy card and return it in the enclosed envelope, which requires no postage stamp if mailed in the United States.

Can I change my proxy?

You may revoke your proxy before it is voted at the Annual Meeting by delivering a signed revocation letter to the Secretary of the Company at 8283 Greensboro Drive, McLean, Virginia 22102, or by submitting a new proxy, dated later than your first proxy, in one of the ways described in the answer to the previous question. If you are virtually attending the Annual Meeting, you may revoke your proxy by virtually attending the Annual Meeting and voting during the Annual Meeting. Virtual attendance at the Annual Meeting will not by itself revoke a proxy.

Can other matters be decided at the Annual Meeting?

What is the vote required for each proposal?

For proposal 1, each of the directors shall be elected by a majority of the votes validly cast at the Annual Meeting. For proposals 2, and 3 and 4, approval of the proposal requires the affirmative vote of a majority of the shares entitled to vote at the Annual Meeting on the subject matter in question represented either in person or by proxy at the Annual Meeting.

What if I am a stockholder of record and do not provide voting instructions when returning a proxy?

Stockholders should specify their choice for each matter on the proxy card. Proxies that are signed and returned but do not contain voting instructions will be voted:

•FOR the election of all director nominees as set forth in this proxy statement;

•FOR the ratification of the appointment of E&Y as the Company's independent registered accounting firm for fiscal year 2026;

•FOR the approval, on a non-binding, advisory basis, of the compensation of our named executive officers; and

•AGAINST the approval, on a non-binding, advisory basis, of the stockholder proposal.

What if I am a beneficial owner and do not give voting instructions to my broker?

If your shares are held by a broker in “street name,” your brokerage firm may vote your shares on certain “routine” matters if you do not provide voting instructions. The ratification of an independent registered public accounting firm is an example of a routine matter. If you do not provide voting instructions, your brokerage firm may either vote your shares on routine matters or leave your shares unvoted. When a brokerage firm votes its customers' shares on a routine matter without receiving voting instructions, these shares are counted both for establishing a quorum to conduct business at the meeting and in determining the number of shares voted for or against the routine matter. A brokerage firm cannot vote your shares on non-routine matters, such as the election of directors and the advisory vote on executive compensation. If your brokerage firm has not received voting instructions on a non-routine matter, these shares will be considered “broker non-votes” to the extent that the brokerage firm submits a proxy.

How are abstentions and broker non-votes counted?

Abstentions will be treated as present for purposes of determining a quorum. Abstentions will have the effect of a vote “against” the proposals for the ratification of an independent registered accounting firm, the advisory vote on the compensation program for the Company's named executive officers, and the stockholder proposal. However, abstentions will have no effect on the outcome of the election of directors.

Broker non-votes are counted for purposes of establishing a quorum. Broker non-votes will have no effect on the outcome of the proposals for the election of directors, the advisory vote on the compensation program for the Company's named executive officers, and the stockholder proposal. Discretionary voting by a broker will be permitted for the proposal for the ratification of an independent registered public accounting firm, which is the only routine proposal.

Who will count the votes?

A representative from Broadridge Financial Services will tabulate the votes and the results will be certified by the inspector of election.

Who will bear the costs of soliciting votes for the Annual Meeting?

The Company will bear all costs of soliciting proxies. Pursuant to rules adopted by the SEC, we have elected to deliver a Notice of Internet Availability of Proxy Materials to you and make the proxy materials available via the Internet at www.proxyvote.com, which may be accessed using the control number located on each proxy card. We have retained the services of Morrow Sodali LLC to assist in the solicitation of proxies for the Annual Meeting. The estimated cost of such services is $15,000, plus reasonable out-of-pocket expenses incurred in the process of soliciting proxies.

When will the Company announce the voting results?

The preliminary voting results will be announced at the Annual Meeting. The Company will report the final results in a Current Report on Form 8-K filed with the SEC.

Can I receive a copy of the Annual Report?

The annual report of the Company on Form 10-K for the fiscal year ended March 31, 2025 is being furnished concurrently with this proxy statement to persons who were stockholders of record as of June 2, 2025, the record date for the Annual Meeting.

What is “householding” and how does it affect me?

In some cases, stockholders holding their shares in a brokerage or bank account who share the same surname and address and have not given contrary instructions are receiving only one copy of our annual report on Form 10-K and this proxy statement. This reduces the volume of duplicate information received at your household and helps to reduce the environmental impact and cost of our Annual Meeting. If you would like to have additional copies of these documents mailed to you, please write or call our Secretary at 8283 Greensboro Drive, McLean, Virginia 22102, telephone: (703) 902-5000. If you want to receive separate copies of the proxy statement, annual report on Form 10-K, or Notice of Internet Availability of Proxy Materials, as applicable, in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker, or other nominee record holder.

How do I submit a proposal for action at the annual of meeting of stockholders in 2025?

Under applicable SEC rules and regulations (including SEC Rule 14a-8), the Company will review for inclusion in next year’s proxy statement stockholder proposals received by February 13, 2026. Proposals should be sent to the Secretary of the Company at 8283 Greensboro Drive, McLean, Virginia 22102.

Pursuant to our Amended and Restated Bylaws, stockholder proposals not included in next year’s proxy statement may be brought before the 2026 Annual Meeting of Stockholders by a stockholder of the Company who is entitled to vote at the meeting, who has given a written notice to the Secretary of the Company at 8283 Greensboro Drive, McLean, Virginia 22102 containing certain information specified in the bylaws and who was a stockholder of record at the time such notice was given and at the date of the 2025 Annual Meeting of Stockholders. Such notice must be delivered to or mailed and received at the address in the preceding paragraph no earlier than March 25, 2026 and no later than April 24, 2026, except that if the date of the 2026 Annual Meeting of Stockholders is changed, and the meeting is held before June 23, 2026 or after October 1, 2026, such notice must be delivered at the address in the preceding paragraph no earlier than 120 days prior to the new date of such annual meeting and not later than the close of business on the later of (i) the ninetieth day prior to the new date of such

annual meeting and (ii) the tenth day following the day on which a public announcement of the new date of such annual meeting is first made.

WEBSITE REFERENCES

Information contained on or connected to any website referenced in this Proxy Statement is not incorporated by reference in this Proxy Statement or in any other report or document we file with the SEC. We routinely use our Investor Relations website to provide presentations, press releases, and other information that may be deemed material to investors. Accordingly, we encourage investors and others interested in the Company to review the information that we share at http://investors.boozallen.com. In addition, our Investor Relations website allows interested persons to sign up to automatically receive e-mail alerts when we post financial information.

APPENDIX A

Non-GAAP Measures

We publicly disclose certain non-GAAP financial measurements, including EBITDA and Adjusted EBITDA, because management uses these measures for business planning purposes, including to manage our business against internal projected results of operations and measure our performance. We view Adjusted EBITDA as a measure of our core operating business, which excludes the impact of the items detailed below, as these items are generally not operational in nature. These non-GAAP measures also provide another basis for comparing period to period results by excluding potential differences caused by non-operational and unusual or non-recurring items. These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry. EBITDA and Adjusted EBITDA are not recognized measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance or liquidity, as applicable, investors should (i) evaluate each adjustment in our reconciliation of net income to EBITDA and Adjusted EBITDA, and the explanatory footnotes regarding those adjustments, each as defined under GAAP, and (ii) use Adjusted EBITDA in addition to, and not as an alternative to net income, as measures of operating results, as defined under GAAP. We have defined EBITDA and Adjusted EBITDA as follows:

•"EBITDA" represents net income attributable to common stockholders before income taxes, net interest expense, net and other income (expense), net, depreciation and amortization.

•"Adjusted EBITDA” represents net income attributable to common stockholders before income taxes, net interest, net and other income (expense), net, and depreciation and amortization and before certain other items, including the change in provision for claimed costs for historical rate years, acquisition and divestiture costs, financing transaction costs, DC tax assessment adjustment, the reserve associated with the U.S. Department of Justice investigation disclosed in Note 20, "Commitments and Contingencies," to the consolidated financial statements contained within our Annual Report on Form 10-K for the fiscal year ended March 31, 2024 and the insurance recoveries related to the settlement of that matter. The Company prepares Adjusted EBITDA to eliminate the impact of items it does not consider indicative of ongoing operating performance due to their inherent unusual, extraordinary or non-recurring nature or because they result from an event of a similar nature.

In addition, we use the following non-GAAP financial measures as performance metrics for our performance-based restricted stock units granted in fiscal year 2025, as described in our proxy statement under the heading, “Compensation Discussion and Analysis—Compensation Elements—Long-Term Equity Incentives—Fiscal Year 2025 Annual Grants”: Adjusted EBITDA and Revenue. Adjusted EBITDA is as defined above, and we define Revenue for purposes of our performance-based restricted stock units as follows:

•“Revenue” represents all consolidated GAAP revenue, adjusted to (i) account for material acquisitions or divestitures during the three-year performance period, but may be adjusted (ii) account for the cumulative impact of GAAP and/or cost accounting standards and financial reporting changes; (iii) account for the impact of government shutdowns during the performance period; and (iv) to exclude the impact of any unusual, infrequently occurring, or restructuring events as described in the Company’s audited financial statements, notes to financial statements or in management’s discussion and analysis in the Company’s annual report for the applicable year that may have a material impact on Revenue results.

A - 1

Below is a reconciliation of EBITDA and Adjusted EBITDA to the most directly comparable financial measure calculated and presented in accordance with GAAP.


	Fiscal Year Ended March 31,
(Amounts in millions)	2025		2024		2023
	(Unaudited)




EBITDA, Adjusted EBITDA
Net income attributable to common stockholders	$	935	$	606	$	272
Income tax expense	284		248		97
Interest expense, net and other income (expense), net (a)	151		160		79
Depreciation and amortization	165		164		165
EBITDA	1,535		1,178		613
Change in provision for claimed costs (b)	(113)		(18)		—
Acquisition and divestiture costs (c)	8		7		44
Financing transaction costs (d)	—		1		7
DC tax assessment adjustment (e)	—		(20)		—
Legal matter reserve (f)	—		27		350
Insurance recoveries (g)	(115)		—		—
Adjusted EBITDA	$	1,315	$	1,175	$	1,014

(a)Reflects the combination of Interest expense, net and Other income (expense), net from the consolidated statement of operations.

(b)Represents the reduction to our provision for claimed costs for years prior to fiscal 2025 recorded during the second quarters of fiscal 2025 and 2024, which resulted in a corresponding increase to revenue, as a result of the Defense Contract Audit Agency's findings related to its audits of our claimed costs for multiple fiscal years. See Note 19, “Commitments and Contingencies,” to the consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2025 for further information.

(c)Represents costs associated with the acquisition efforts of the Company related to transactions for which the Company has submitted a letter of intent to acquire a controlling financial interest in the target entity. Transactions primarily include the acquisitions of EverWatch Corp. (“EverWatch”) in fiscal 2023 and PAR Government Systems Corporation (“PGSC”) in fiscal 2025. See Note 5, “Acquisitions and Divestitures,”to the consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2025 for further information.

(d)Reflects expenses associated with debt financing activities incurred during the second quarters of fiscal 2024 and 2023.

(e)Reflects the impact (specifically the revenue from recoverable expenses) of the Company's unfavorable ruling from the District of Columbia Court of Appeals related to contested tax assessments from the District of Columbia Office of Tax and Revenue (“DC OTR”). See Note 13, “Income Taxes,” to the consolidated financial statements contained within the Annual Report on Form 10-K for the fiscal year ended March 31, 2024 for further information.

(f)Reserve associated with the U.S. Department of Justice's investigation of the Company. See Note 20, “Commitments and Contingencies,” to the consolidated financial statements contained within the Annual Report on Form 10-K for the fiscal year ended March 31, 2024 for further information.

(g)Reflects insurance recoveries from claims related to the Company’s fiscal 2024 settlement as described in Note 19, “Commitments and Contingencies,” to the consolidated financial statements in the Company's Form 10-K for the fiscal year ended March 31, 2025 for further information.

A - 2

[THIS PAGE INTENTIONALLY LEFT BLANK]

BOOZ ALLEN HAMILTON HOLDING CORPORATION_V_CV_PRXY_GT20_P27728_25(#88430) - C3_Page_1.jpg

BOOZ ALLEN HAMILTON HOLDING CORPORATION_V_CV_PRXY_GT20_P27728_25(#88430) - C3_Page_2.jpg

Get the next $BAH alert in real time by email

Date	Price Target	Rating	Analyst
6/24/2025	$112.00	Hold	Stifel
5/28/2025	$94.00	Neutral → Sell	Goldman
5/23/2025		Outperform → Mkt Perform	Raymond James
4/11/2025	$109.00	Buy → Neutral	Goldman
2/21/2025		Outperform → Mkt Perform	William Blair
2/7/2025	$160.00	Overweight	Cantor Fitzgerald
2/3/2025	$150.00	Mkt Perform → Outperform	Raymond James
1/6/2025	$140.00	Underweight → Equal Weight	Barclays

SEC Form DEF 14A filed by Booz Allen Hamilton Holding Corporation

Crush Q3 2025 with the Best AI Executive Assistant

Recent Analyst Ratings for $BAH

$BAH Press Releases

Fastest customizable press release news feed in the world

Booz Allen Invests in Corsha to Safeguard U.S. Critical Infrastructure

BetterInvesting™ Magazine Update on Booz Allen Hamilton (NYSE: BAH) and Nike (NYSE: NKE)

Booz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2026 Results on Friday, July 25, 2025

$BAH SEC Filings

SEC Form DEFA14A filed by Booz Allen Hamilton Holding Corporation

SEC Form DEFA14A filed by Booz Allen Hamilton Holding Corporation

SEC Form DEF 14A filed by Booz Allen Hamilton Holding Corporation

$BAH Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Stifel resumed coverage on Booz Allen Hamilton with a new price target

Booz Allen Hamilton downgraded by Goldman with a new price target

Booz Allen Hamilton downgraded by Raymond James

$BAH Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & Chief Financial Officer Calderone Matthew gifted 496 shares, decreasing direct ownership by 1% to 35,529 units (SEC Form 4)

New insider Obrien Robert C claimed no ownership of stock in the company (SEC Form 3)

Director Rossotti Charles O gifted 8,088 shares, decreasing direct ownership by 57% to 5,999 units (SEC Form 4)

$BAH Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Amble Joan Lordi bought $121,737 worth of shares (930 units at $130.90), increasing direct ownership by 2% to 56,860 units (SEC Form 4)

Director Amble Joan Lordi bought $100,505 worth of shares (690 units at $145.66), increasing direct ownership by 1% to 55,930 units (SEC Form 4)

Director Amble Joan Lordi bought $294,260 worth of shares (2,000 units at $147.13), increasing direct ownership by 4% to 55,240 units (SEC Form 4)

$BAH Financials

Live finance-specific insights

Booz Allen Hamilton to Host Conference Call to Discuss First Quarter Fiscal 2026 Results on Friday, July 25, 2025

Booz Allen Hamilton Announces Fourth Quarter and Full Fiscal Year 2025 Results

Booz Allen Hamilton to Host Conference Call to Discuss Fourth Quarter and Full Year Fiscal 2025 Results on Friday, May 23, 2025

$BAH Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation

SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation (Amendment)

SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation (Amendment)

$BAH Leadership Updates

Live Leadership Updates

Booz Allen Appoints Ambassador Robert C. O'Brien to Board of Directors

Booz Allen Appoints Andrea Inserra and Steve Escaravage to New Leadership Roles

Booz Allen Appoints Debra L. Dial to Board of Directors

Recent Analyst Ratings for
$BAH

$BAH
Press Releases

$BAH
SEC Filings

$BAH
Analyst Ratings

$BAH
Insider Trading

$BAH
Insider Purchases

$BAH
Financials

$BAH
Large Ownership Changes

$BAH
Leadership Updates